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An exhaustive understanding of the major cellular signaling pathways in biology is key to 
future innovations in oncology, regenerative medicine and gene therapy. The Wnt/b-
catenin signaling pathway represents one such pathway. It influences cell proliferation, 
self-renewal, migration, embryonic development and cancer. In this pathway, the effect of 
extracellular Wnt ligands is mediated by a cytosolic effector protein, b-catenin, which 
activates downstream genes. However, the exact mechanism of action for this pathway 
remains controversial. Our analysis asserts that the disassembly of a fraction of the 
intracellular destruction complexes results in the partial inhibition of both b-catenin 
phosphorylation and ubiquitination and this disassembly is correlated with these 
destruction complexes relocating to the cellular membrane upon Wnt stimulation.  In 
contrast to the generally accepted view, our model also suggests that b-catenin can 
dissociate from the complex between sequential phosphorylation and ubiquitination events. 
Our insights from the above model led us to strategically design synthetic multivalent 
molecules that can mimic the effects of the canonical Wnt ligands. The application of Wnt 
proteins in industrial bioprocesses and therapy are currently limited by the difficulty 
associated with the efficient production and characterization of the Wnt proteins and the 
synthetic Wnt agonists described in this work can thus serve as efficient, viable and 
scalable alternatives to these wild-type Wnt proteins. 
In parallel to the work described above, we applied our understanding of the dynamics of 
the canonical Wnt receptor protein LRP6 to design a library of tunable blue light-(l=488 
nm)-sensitive photoswitches with a range of oligomerization efficiencies and dissociation 
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dynamics. Finally, we proposed the design of field-deployable sentinel cells to monitor the 
quality of cardiomyocyte production from human induced pluripotent stem cells (iPSCs) 
via modulation of Wnt signaling. As a proof-of-concept, we designed transcriptional 
switches to detect key biomarkers of different stages of cardiomyocyte differentiation 
specifically and assert that these reporters can form the basis of the above-mentioned 
sentinel cells. 
Taken together, the work described in this thesis can serve as a platform for investigating 
the role of the canonical Wnt signaling pathway in a wide array of biological phenomena 
and its subsequent integration in future bioprocessing workflows.
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CHAPTER 1.    INTRODUCTION 
1.1   Motivation 
Cellular signaling pathways are biomolecular networks that have evolved to govern 
the activities of the cell (Kitano et al. 2002; Bhattacharyya et al. 2006). At the cellular level, 
these pathways are responsible for a gamut of biological functions that range from 
transcriptional, translational, and post-translational regulation within the cell to exerting 
short and long-range effects on neighboring cells (Elowitz et al. 2000; Mann et al. 2003; 
Culler et al. 2010). Thus, an interplay of the pathways helps cells communicate with one 
another to perform the most crucial biological functions in an organism. In modern 
medicine, our understanding of signaling pathways holds the key to unlocking new insights 
in regenerative medicine, as well as discovering innovative treatment regimens in oncology 
and congenital and hereditary diseases (Reya et al. 2001; Androutsellis-Theotokis et al. 
2006; Niederreither et al. 2008). A couple of examples come immediately to mind; the 
recent advent of CAR-T cell therapy was made possible by decades of literature studying 
the pathways underlying antigen recognition and the subsequent activation of various 
immune cells (Kalos et al. 2011; Irving et al. 1991; Harada et al. 1993; Levine et al. 1997). 
The promising Cas9-mediated gene-editing approach that has captured the imagination of 
the scientific community was preceded by a fundamental understanding of Cas9’s role in 
CRISPR-mediated prokaryotic immune pathways, something that was made possible by 
about two decades’ worth of scientific studies (Landers 2016; Ishino et al. 1987; Mojica et 
al. 1993; Mojica et al. 2000; Jansen et al. 2002; Bolotin et al. 2005). 
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There is, of course, a lot that remains unexplored in these fields, and the challenges 
faced in these disciplines often lead back to an incomplete understanding of the 
underpinning pathways (Takebe et al. 2010; Gnimassou et al. 2017). Controversies 
regarding various aspects of these pathways, e.g. the developmental signaling pathways, 
are commonplace (Azzolin et al. 2014; Park et al. 2015; Lin et al. 2010; Tosi et al. 2018). 
It is almost never due to the lack of effort, resources or collective intellect, but rather a lack 
of engineering tools available to settle the dispute decisively. However, as new tools and 
methods emerge over time, applying such tools to revisit these controversies often lead to 
radically impactful insights in the above disciplines (Hell et al. 1994; Huang et al. 2010; 
Zhang et al. 2016; Igarashi et al. 2018). When such progress is combined with other 
methods, they often result in the implementation of radical new approaches in a therapeutic 
and/or bioprocessing context. For example, citing a previously mentioned instance, CAR-
T therapy came about only when the fundamental understanding of our immune pathways 
was combined with an expertise in synthetic biology, clinical intervention, and scalable 
bioprocessing (Wu et al. 2015; Lim and June 2017). 
The Wnt family of signaling pathways represents examples of the aforementioned 
cellular signaling pathways (Fig. 1). After the first of these pathways was discovered 
almost 35 years ago, research on these family of pathways has revealed that they are 
ubiquitous in the animal kingdom on top of being highly evolutionarily conserved like 
many other developmental pathways (Clevers 2006; Clevers and Nusse 2012). The 
capability to understand and modulate these pathways thus represents a significant 
milestone in modern medicine (Moon et al. 2004, Baron et al. 2013). As a result, almost 
predictably, there has been no shortage of conflicting opinions regarding almost all aspects 
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of the Wnt pathways (Desbois-Mouthon et al. 2001, Mao et al. 2001, Cselenyi et al. 2008). 
There is a clear need for a better understanding of the Wnt pathways, and consequently 
there is a need for better tools, to further probe and modulate these pathways. Hence, we 
decided to focus our efforts in this thesis on elucidating the nuances of the canonical Wnt 
signaling pathway (also known as the Wnt/b-catenin pathway). However, as we move 
along, we ponder how to potentially translate our approach and findings to the other 
(noncanonical) Wnt pathways and other developmental pathways. Additionally, our 
understanding of recombinant protein expression and synthetic biology represent key 
cornerstones of this thesis.  
 
Figure 1 – Overview of the Wnt Signaling Pathways: Schematic showing the OFF and 
ON stages of the canonical Wnt pathway (left, left-center) and two noncanonical Wnt 
pathways, the planar cell polarity pathway (PCP) (right-center) and the Wnt-calcium 
pathway (Wnt/Ca2+) (right). Reprinted from www.abcam.com. 
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1.2   Brief History of the Wnt Signaling Pathways 
The first Wnt gene, the Wnt1 gene (then termed Int1), was discovered in 1982 by 
Harold Varmus and Roel Nusse while studying the molecular mechanism of infection by 
the oncogenic mouse mammary tumor virus (MMTV) (Nusse and Varmus 1982). To 
provide context, two of the more well-known pathways with broad-ranging implications in 
therapy, viz., the TGF-b and the p53 pathways were discovered in 1978 and 1979 
respectively (Moses et al. 2016; DeLarco and Todaro 1978; Kress et al. 1979; Lane and 
Crawford 1979; Linzer and Levine 1979). In the late 1980s and early 1990s, within the first 
decade of the discovery of the Wnt1 gene, extensive studies in Drosophila and Xenopus 
indicated that the Wnt loci of genes, and the related pathways, are highly conserved among 
different species of the animal kingdom (Clevers and Nusse 2012). 
A clearer picture of the canonical Wnt signaling pathway was predominantly 
developed in the 1990s. In the early 1990s, systematic epistasis studies in Drosophila led 
to the recognition of the core axis of proteins (genes) making up the Wnt transduction 
cascade, viz., disheveled (Dvl), armadillo (b-catenin), and GSK3 (Bhanot et al. 1996; 
Molenaar et al. 1996). During the same time, mutations in the adenomatous polyposis coli 
(APC) gene were implicated in familial adenomatous polyposis (FAP), a hereditary 
condition that predisposes patients to a high lifetime risk of colon cancer (Nishisho et al. 
1991; Peifer and Polakis 2000). The first evidence of the Wnt pathways’ involvement in 
diseases was reported in 1994 (Table 1), when the APC protein was shown to interact 
robustly with b-catenin, one of the core proteins of the Wnt axis (Su et al. 1993). In the late 
1990s, the T-cell Factor/Lymphoid Enhancer-Binding Factor (TCF/LEF) family of 
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transcription factors was identified as key nuclear effectors of the Wnt pathway 
(Vandewetering et al. 1991; Behrens et al. 1996). Subsequently, the membrane receptors 
Frizzled and co-receptors Arrow and LRP5/6 were identified to be working together to 
bind the extracellular Wnt ligand and playing a key role in transducing the signal across 
the membrane (Wehrli et al. 2000; Cong et al. 2004). 
Table 1 – Diseases Associated with Mutations in Wnt Pathway Components 
Type of Mutation Wnt Proteins Examples of Associated Diseases 
Gain-of-Function b-catenin Cancer 
Loss-of-Function APC Familial Adenomatous Polyposis 
Loss-of-Function Axin1 Caudal Duplication Syndrome 
Gain-of-Function TCF4 Type II Diabetes 
Loss-of-Function LEF1 Sebaceous Skin Tumor 
Since the turn of the new millennium, studies have revealed multiple additional 
components to the canonical Wnt pathway. Among them are the naturally secreted 
agonists, such as R-Spondins (RSPO) and Norrin, as well as the receptors Lgr4 and Lgr5 
that specifically bind RSPO to enhance Wnt signaling in vivo (Xu et al. 2004; Kazanskaya 
et al. 2004; Glinka et al. 2011). Many naturally occurring antagonists, with different 
mechanisms of inhibition, have also been reported. For example, the Dickkopf (Dkk) 
family of proteins inhibits the Wnt signal transduction by binding the co-receptors LRP5/6 
while secreted Frizzled-related proteins (sFRPs) directly bind to the canonical Wnt ligands 
and prevent their binding to their respective co-receptors (Glinka et al. 1998; Bovolenta et 
al. 2008). Identifying natural and synthetic agonists and antagonists of the canonical Wnt 
signaling pathway, and deciphering their role in various Wnt-modulated processes, remain 
an active field of research today. 
 6 
In addition, multiple new members of the Wnt family of proteins and subsequently, 
several noncanonical Wnt pathways have been reported. To date, 19 Wnt genes (proteins) 
of 12 distinct subfamilies have been reported in the literature. Among the noncanonical 
Wnt pathways, the planar cell polarity (PCP) pathway and the Wnt-Calcium (Wnt/Ca2+) 
signaling cascade are relatively well-known (Fig. 1) (Clevers and Nusse 2012). An 
alternative Wnt pathway was reported as recently as 2015 (Park et al. 2015). The 
mechanism of action of a large majority of these noncanonical Wnt pathways remain 
poorly characterized and hence their roles poorly understood from a biological standpoint. 
1.3   General Overview of the Canonical Wnt Signaling Pathway 
The transduction of the canonical Wnt signal is mediated by specific components 
in the extracellular space, the cellular membrane, the cell cytosol and the nucleus. It is a 
paracrine pathway and the effect of Wnt is widely considered to be a short-range, i.e., cells 
secreting the canonical Wnt ligands largely trigger this pathway in other cells in their 
immediate neighborhood (Clevers and Nusse 2012; Korkut et al. 2009; Sato et al. 2011). 
In the absence of Wnt, cells (hereby referred to as Wnt OFF cells) maintain an 
extremely low cytosolic concentration of the Wnt effector protein, b-catenin, at steady 
state. This low concentration is due to the efficient functioning of a large, dynamic, multi-
protein assembly known as the destruction complex (Fig. 2) (Stamos and Weis 2013). The 
destruction complex consists of scaffolding proteins, viz., Axin (Axin1), adenomatous 
polyposis coli (APC), as well as enzymes, viz., glycogen-synthase kinase 3b (GSK3b) and 
casein kinase 1a (CK1a). The scaffolding proteins largely ensure the proper assembly of 
the destruction complex, while the enzymes are responsible for the post-translational 
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modifications of b-catenin (Stamos and Weis 2013). In Wnt OFF cells, the cytosolic b-
catenin is taken up by the destruction complex, sequentially mono-phosphorylated by 
CK1a, tri-phosphorylated by GSK3b and ubiquitinated by the b-TrCP E3 ubiquitin ligase 
complex (Hart et al. 1999; Amit et al. 2002; Liu et al. 2002; Wu et al. 2003). The ubiquitin-
tagged b-catenin is then degraded extremely fast by the proteasome via the Ubiquitin-
Proteasome Pathway (UPP), which in turn results in the miniscule cytosolic amounts of b-
catenin (Fig. 2) (MacDonald et al. 2009).  
However, the cell surface co-receptors Frizzled and LRP5/6 form a heterodimeric 
complex in presence of the canonical Wnt ligand (e.g. Wnt-3a) (Bhanot et al. 1996; Wehrli 
et al. 2000; Dann et al. 2001). Upon this complex formation, the destruction complex 
function in these cells (hereby referred to as Wnt ON cells) is disrupted (Cong et al. 2004). 
This disruption results in an accumulation of b-catenin in the cytosol over time which leads 
to the translocation of large amounts of b-catenin to the nucleus (Cong et al. 2004). In the 
nucleus, b-catenin acts as a transcriptional co-activator. It is recruited by the TCF/LEF 
family of transcription factors (already present in the nucleus) to the enhancer elements of 
the downstream Wnt target genes in the nucleus, thereby increasing the likelihood of 
expression of these genes (Behrens et al. 1996; vandeWetering 1997). The activation of 
these genes has far-reaching implications in the development of the Wnt ON cells as these 
genes influence key phenomena such as cell proliferation, self-renewal, differentiation etc. 
(Wodarz and Nusse 1998). 
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Figure 2 – Role of Destruction Complex in b-catenin Degradation: Schematic showing 
sequential phosphorylation by CK1a (CK1) and GSK3b (GSK3) followed by 
degradation by the Ubiquitin-Proteasome Pathway (UPP). 
1.4   Challenges and Specific Aims 
Evidently, the capability to modulate the canonical Wnt pathway represents a 
powerful tool for modern medicine.  However, despite its discovery more than 35 years 
ago, this remains exquisitely challenging for a multitude of reasons. 
1.4.1   Fundamental mechanism of the canonical Wnt pathway remains unclear 
As mentioned above, researchers have attempted to decipher the fundamental 
mechanism of the canonical Wnt pathway since the early ‘90s. While they have discovered 
numerous (though, not all) essential components of the canonical Wnt pathway, the exact 
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biophysical mechanism underlying the signal transduction remains controversial 
(Hernandez et al. 2012; Li et al. 2012). 
1.4.2   Challenging to produce and characterize Wnt ligands 
The canonical Wnt proteins e.g. Wnt1 and Wnt-3a, are ~40 kDa proteins with 
multiple conserved cysteine residues (Tanaka et al. 2002). Moreover, these proteins are 
lipid modified and these lipids are essential for their signaling activity and may even be 
important for their secretion. For example, analysis of the purified mouse Wnt-3a revealed 
that it contains a palmitoleic acid moiety on a conserved serine residue (Janda et al. 2012; 
Clevers and Nusse 2012). The presence of these lipids makes the purification of the Wnt 
proteins extremely difficult, thus hindering the scalability of many Wnt-dependent 
bioprocessing workflows (Clevers and Nusse 2012; Janda et al. 2017). 
1.4.3   Translating understanding of Wnt pathway to building orthogonal molecular 
biology tools 
Understanding the details of the biophysical and biochemical phenomena 
associated with different components of cell biological pathways enables us to successfully 
develop new molecular biology tools that find potential applications in other contexts. 
However, our incomplete understanding of the canonical Wnt signaling pathway have 
limited the development of such orthogonal tools that are widely applicable.  
1.4.4   Insufficient correlation between Wnt signaling and downstream pathways 
As a direct consequence of the challenges associated with the pathway, it has been 
difficult to study the influence of the canonical Wnt signaling to its downstream signaling 
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networks. While it is known that Wnt plays an essential role in critical functions of the cell, 
especially in stem cells, such as proliferation and self-renewal, the exact chain of events 
that lead to these phenomena remains underexplored (Matushansky et al. 2008). 
In this thesis, we attempted to address the concerns mentioned above. Our overall 
objective was to design an approach to derive novel insights into the fundamental 
mechanism of the canonical Wnt signaling pathway and subsequently, to utilize our 
understanding to develop a variety of cell biological tools to facilitate future investigations 
into the pathway. The following were our specific aims: 
Specific Aim 1: Elucidate the Fundamental Mechanism of the Canonical Wnt Signaling 
Pathway 
a.   Ascertaining the rate-limiting step in inhibition of b-catenin degradation 
b.   Exploring the biophysical basis of Wnt signal transduction in the cytosol 
c.   Understanding the nature of destruction complex-b-catenin interaction 
Specific Aim 2: Producing Synthetic Multivalent Agonists of Canonical Wnt Signaling 
a.   Standardizing the strategy and purification of divalent canonical Wnt agonists 
b.   Validating the activity and efficacy of Wnt agonists in vitro 
Specific Aim 3: Designing Tunable Optogenetic Photoswitches 




Specific Aim 4: Designing Transcriptional Switches as Alternate Reporters in Wnt-
modulated Generation of Cardiomyocytes 
a.   Constructing and validating transcriptional activation-based reporters of 




CHAPTER 2.   ELUCIDATE THE FUNDAMENTAL MECHANISM 
OF THE CANONICAL WNT SIGNALING PATHWAY 
2.1   Background 
Ever since the discovery of the core components of the canonical Wnt pathway in 
the 1990s, numerous mechanisms have been proposed in the literature to explain the 
increase in cytosolic b-catenin in presence of the canonical Wnt ligands. Several of these 
models revolved around the concept of Wnt-mediated disruption of the activity of Axin1, 
the protein which was widely considered the rate-limiting component of the destruction 
complex. Mao et al. and Zeng et al. suggested that the dephosphorylation and 
destabilization of Axin1 upon its membrane sequestration is largely responsible for 
stabilization of cytosolic b-catenin (Mao et al. 2001; Zeng et al. 2005). Along the same 
lines, several studies proposed the physical dissociation of Axin1 (and APC) from the 
destruction complex and its subsequent degradation in the cell being the key driver behind 
canonical Wnt signaling (Logan and Nusse 2004).  
A contemporary school of thought (in the early 2000s) suggested that inhibition of 
phosphorylation of b-catenin is primarily responsible for its increased concentration. 
Cselenyi et al. and others suggested that the cytosolic domain of phosphorylated LRP6 
inhibits GSK3 kinase activity whereas Taelman et al. suggested that vesicular bodies within 
the cytosol sequester the GSK3 enzyme to prevent it from interacting with the destruction 
complex and b-catenin in the first place (Cselenyi et al. 2008; Taelman et al. 2010). Some 
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studies also posited a role for phosphatases such as PP2A in dephosphorylating, and thus 
stabilizing, cytosolic b-catenin (Su et al. 2008). 
As indicated by Li et al., the above studies mostly suffered from a key drawback, i.e. 
utilizing an overexpression strategy in probing the Wnt pathway (Li et al. 2012). A few 
Wnt components are present in very small amounts in the cytosol, and hence the dynamics 
of the Wnt pathway is severely modified when one or more of these components are 
expressed at a significantly higher level than that usually found in the organism. However, 
recent innovations have allowed us to circumvent the need for overexpression by being 
able to accurately detect nanomolar levels of proteins. As a result, recent controversies in 
the field have circled around two main competing mechanisms; a) the inhibition of 
phosphorylation and b) the inhibition of ubiquitination of b-catenin (Fig. 3) (Hernandez et 
al. 2012; Kim et al. 2013; Li et al. 2012; Azzolin et al. 2014). 
 
Figure 3 – Two Competing Models of Canonical Wnt Signaling: Model 1 has been 
proposed by Hernandez et al. and Kim et al. and asserts that CK1 and GSK3 
phosphorylation are rate-limiting steps. Model 2 shows inhibition of only the 
ubiquitination step as suggested by Li et al. and Azzolin et al.  
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In 2012, Li et al. ruled out the possibility of Axin1 degradation being the key cause 
behind b-catenin accumulation. Upon Wnt-3a stimulation, they found that the 
accumulation of b-catenin was detectable after 30 minutes while any noticeable 
degradation of Axin1 took at least ~4 hours (Li et al. 2012). To probe the pathway, they 
co-immunoprecipitated Axin1 and thus pulled down the proteins associated with the 
destruction complex. They observed that the same proteins were pulled down along with 
Axin1 before and after the addition of Wnt-3a, suggesting that the destruction complex 
doesn’t fall apart. Moreover, they reported that the concentrations of CK1-phosphorylated-
b-catenin (hereby referred to as CK1-p-b-catenin) and GSK3-phosphorylated-b-catenin 
(hereby referred to as GSK3-p-b-catenin) associated with Axin1 increased after Wnt 
stimulation. They also observed that the amount of ubiquitinated GSK3-p-b-catenin 
associated with Axin1 decreased after Wnt stimulation. This decrease led them to conclude 
that “Wnt signaling suppresses β-catenin ubiquitination normally occurring within the 
complex, leading to complex saturation by accumulated phospho-β-catenin.” (Li et al. 
2012). Complex saturation would make the destruction complexes unavailable for 
degrading β-catenin, leading to a rise in β-catenin concentration in the cytosol. In 2014, 
Azzolin et al. reported that Hippo transducer proteins YAP/TAZ form a part of the 
destruction complex and are essential for the docking of the β-TrCP ubiquitin E3 ligase 
(Azzolin et al. 2014). They observed that Wnt signaling caused YAP/TAZ to be released 
from the destruction complex. This, in turn, prevented the docking of the E3 ligase to the 
destruction complex, thus inhibiting the ubiquitination of β-catenin.  
In the same year, Hernandez et al. proposed a contradictory model to that of Li et al. 
They suggested that the CK1a (hereby referred to as CK1) and the GSK3b (hereby referred 
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to as GSK3)-phosphorylation of b-catenin were the rate controlling steps in the canonical 
Wnt signaling pathway (Hernandez et al. 2012). They arrived at this conclusion by 
measuring the temporal variation in concentrations of different types of cytosolic and 
nuclear b-catenin upon Wnt-3a stimulation in mammalian cells. They observed that the 
total cytosolic b-catenin concentration increased monotonically and then plateaued over 
time to reach a new steady-state concentration. However, the levels of CK1-phosphorylated 
(CK1-p-b-cat) and GSK3-phosphorylated b-catenin (GSK3-p-b-cat) decreased initially (to 
different extents) and subsequently recovered over time, reaching a new steady-state. They 
also showed that the minimum in GSK3-p-b-cat concentration coincided in time with the 
maximum in the rate of accumulation of total b-catenin. In 2013, Kim et al. also reported 
that the ratio of GSK3-p-b-catenin to total b-catenin concentration fell precipitously upon 
Wnt stimulation, but never recovered over time (Kim et al. 2013). They argued that this 
observation conclusively proved that phosphorylation was the rate controlling step. While 
both studies did not explicitly comment on the destruction complex, Hernandez et al. 
mentioned that their model was consistent with the destruction complex falling apart. 
Commenting on the Li et al. study, Hernandez et al. argued that an inactivation-via-
saturation of the destruction complex offers no possibility of a recovery of the degradation 
flux. A lack of such a recovery will lead to a runaway accumulation of b-catenin in the 
cytosol and is thus inconsistent with the experimental observations. 
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2.2   Material and Methods 
Antibodies  
The anti-APC antibody (Cell signaling Technology, #2504) was used for co-
immunoprecipitation only. The anti-Axin1 antibody (Cell Signaling Technology; #2087) 
was used for both co-immunoprecipitation and immunoblotting. The following antibodies 
were used for immunoblotting only: anti-b-catenin (BD Transduction Laboratories; 
#610153), anti-phospho-b-catenin antibody (Ser33/37/Thr41) (Cell Signaling Technology; 
#9561), anti-phospho-b-catenin antibody (Ser45) (Cell Signaling Technology; #9564), 
anti-LRP6 (C5C7) antibody (Cell Signaling Technology; #2560), anti-APC (Abcam, 
#ab15270), anti-biotin (Abcam, #ab53494), anti-a-tubulin (Abcam; #ab52866), anti-
GAPDH (Abcam; #ab8245), and monoclonal rabbit IgG isotype control (Abcam, 
#ab172730). 
Mammalian Cell Culture and Treatment with Wnt-3a and MG132  
Human embryonic kidney (HEK) 293T cells were purchased from the American Type 
Culture Collection (ATCC) and cultured in D-10 (DMEM with 10% HI-FBS; Gibco, 
Thermo Scientific) media in a humidified incubator at 37°C with 5-8% CO2. Cultured cells 
were treated with recombinant human Wnt-3a (Bio-Techne) at a final concentration of 
~800 ng/ml. MG132 (Sigma-Aldrich) treatments were done at a final concentration of 10 
µM (liquid MG132 stock diluted directly in D-10 media immediately before treatment).  
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Preparation of Whole-cell Lysates and Cytoplasmic and Nuclear extracts 
293T cells were cultured in 6-well tissue culture plates (Corning) and grown up to 90% 
confluency. After treatment, the cells were washed in ice-cold DPBS (Corning) twice and 
80 µL of lysis buffer, consisting of 0.5% (w/v) digitonin (pH 7.5) in DPBS (Kim et al. 
2013), was added to each well. The lysis buffer was supplemented with N-ethylmaleimide 
(Sigma-Aldrich) at a concentration of 5 µM and phosphatase inhibitor (Sigma-Aldrich) and 
protease inhibitor cocktails (Thermo Scientific) at dilutions recommended by the 
manufacturer. The lysates were incubated on ice for 30-45 min for complete lysis and 
harvested using cell scrapers (Grainger). The lysates were then cleared by centrifuging at 
13,000g for ~15 min. The clear, debris-free supernatant was collected for further analysis 
for each lysate. These represented the whole-cell lysates. 
Next, we obtained the cytoplasmic and nuclear extract by incubating the above supernatant 
with Concanavalin A-Sepharose 4B beads (GE Healthcare) for 60 min at 4°C with 
continuous end-over-end mixing. The slurry was then centrifuged at 4000g for ~5 mins. 
The membrane-associated proteins were bound to the Concanavalin A beads and the 
supernatant consisted of the cytoplasmic and nuclear fractions of the lysate. The beads were 
then washed 5 times with DPBS and denatured directly in 2x LDS Sampling Buffer 
(Thermo Scientific) followed by immunoblotting (western blotting) to analyze membrane-
associated proteins. The supernatants from both whole-cell and cytoplasmic and nuclear 
lysates were denatured in 1x LDS Sampling Buffer (Thermo Scientific) by heating at 
100°C for 10-15 mins. We then proceeded to immunoblotting (western blotting) for further 
analysis. 
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Detection of Newly-Synthesized b-catenin 
293T cells were cultured in 15-cm tissue culture dishes (Corning) at an initial concentration 
of 15 million cells per dish for 36-48 h in D-10 media. First, the cells were treated with 
Wnt-3a for the indicated time periods. Next, the D-10 media was removed and the cells 
were washed twice with DPBS followed by one wash with methionine-free, cystine-free 
Dulbecco’s Modified Eagle Medium (DMEM) (Thermo Scientific) consisting of 4-6 mM 
of L-Azidohomoalanine (L-AHA) (Anaspec). The cells were then treated with the wash 
media containing 10 µM MG-132 (Sigma-Aldrich) and Wnt-3a for the indicated time 
periods. The cells were then washed twice with ice-cold DPBS (Corning) and lysed using 
2% SDS in DPBS containing phosphatase and protease inhibitor cocktails at concentrations 
prescribed by the manufacturers. The lysates were subsequently denatured and processed 
as described by Dieterich et al. and Debets et al. (Dieterich et al. 2007; Debets et al. 2010).  
Co-Immunoprecipitation (Co-IP) 
293T cells were cultured in 15-cm tissue culture dishes (Corning) at an initial concentration 
of 15 million cells per dish and incubated in D-10 media until 80% confluency was 
achieved. Cells were treated for the indicated time periods with Wnt-3a followed by two 
washes in ice-cold DPBS (Corning). They were then lysed in a lysis buffer of the following 
recipes: 
a.   For anti-Axin1 co-IP: 150 mM NaCl, 30 mM Tris (pH 7.5), 1 mM EDTA, 1% 
Triton X-100, 10% Glycerol. 
b.   For anti-APC co-IP: 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM 
EDTA, 5% glycerol. 
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Lysis buffers were supplemented with phosphatase inhibitor cocktails 2 & 3 (at 1:100 
dilution) (Sigma-Aldrich), Halt protease inhibitor cocktail (at 1:100 dilution) (Thermo 
Scientific), 0.1 mM phenylmethylsulfonyl fluoride (PMSF) and 0.5 mM Dithiothreitol 
(DTT). The cells were then incubated on ice for 30 mins, harvested using a cell scraper and 
centrifuged to collect the supernatant (whole-cell lysate) as mentioned earlier in this 
section. 
Cell lysates were pre-cleared by incubating with Rabbit IgG isotype control antibody for 4 
hours followed by Pierce Protein A Magnetic beads (Thermo Scientific) for 2 hours at 4°C. 
The magnetic beads were then separated out using a magnetic rack (MagnaRack; Thermo 
Scientific) and the supernatant incubated overnight with the appropriate 
immunoprecipitating antibody at 4°C with constant end-over-end mixing. This represented 
the “pull-down” step. The lysates were then incubated in Protein A-conjugated magnetic 
beads for 2 hours at 4°C with constant mixing to isolate the antibody. The magnetic beads 
were then separated again using the MagnaRack, washed 5 times with Tris-Buffered Saline 
(TBS) containing 0.1% Tween-20 followed by 1 wash with TBS. The beads were then 
denatured in 2x LDS Sampling Buffer (containing 2% v/v 2-mercaptoethanol) by heating 
at 100°C for ~15 mins. The heating denatures the proteins pulled down with the Protein A 
beads completely. The magnetic beads were then separated using the MagnaRack and the 
supernatant containing the immunoprecipitated proteins further analyzed. 
SDS-PAGE Gel Electrophoresis and Immunoblotting 
High-molecular weight proteins (100 - 400 kDa) and medium to low-molecular weight 
proteins (20 kDa - 100 kDa) in the lysates were resolved using SDS-PAGE Gel 
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Electrophoresis in 3-8% Tris-Acetate and 4-12% Bis-Tris Polyacrylamide gels respectively 
using an OWL P8DS (Thermo Scientific) gel-running apparatus. The proteins were then 
transferred using the Trans-Blot Turbo Transfer System (Bio-Rad) to a nitrocellulose 
membrane. 
For immunoblotting, the membrane was blocked in a blocking buffer (1x TBS with 0.1% 
Tween-20 and 5% non-fat dry milk or BSA; as per antibody manufacturer’s 
recommendation) for 1 hour at room temperature. The membrane was then incubated 
overnight at 4°C in primary antibody diluted in 5% BSA in TBST (1x TBS containing 
0.1% Tween-20). The dilution used for different primary antibodies are as follows: 
a. Anti-Axin1, anti-b-catenin, anti-phospho-b-catenin antibody (Ser33/37/Thr41), anti-
phospho-b-catenin antibody (Ser45), anti-LRP6 (C5C7) antibody: 1:1000  
b. Anti-a-tubulin, anti-GAPDH: 1:5000 
c. Anti-APC: 1:500 
Next, the membrane was washed three times with TBST for 5 minutes each and then 
incubated in secondary antibody diluted in the blocking buffer for 1 hour at room 
temperature with constant mixing. An HRP-conjugated anti-mouse antibody (Jackson 
Immunoresearch) was used to detect total b-catenin and GAPDH at a dilution of 1:10000. 
All other proteins were detected using an HRP-conjugated anti-rabbit antibody (Thermo 
Scientific) at a dilution of 1:3000. The membrane was then imaged in a ChemiDoc MP 
Imaging system (Bio-Rad) after ~1 minute of incubation in the SuperSignal West Femto 
Maximum Sensitivity Substrate. The detected protein bands were quantified using the 
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analysis tools provided in the Image Lab Software (Bio-Rad) and then validated using 
ImageJ. 
2.3   Results 
2.3.1   Monitoring temporal dynamics of b-catenin upon canonical Wnt signaling 
To investigate, we proceeded by monitoring temporal changes in levels of b-catenin 
in 293T cells upon Wnt-3a stimulation.  From previous reports, we knew that a significant 
amount of b-catenin in these cells remain associated with the E-cadherin complexes in the 
plasma membrane (Hernandez et al. 2012). By current understanding, these represent a 
highly stable pool of b-catenin which are not involved in canonical Wnt signaling. Hence, 
to monitor changes in the level of free (cytosolic and nuclear) b-catenin over time, we 
incubated the whole cell lysates with Concanavalin A-Sepharose 4B beads (which 
selectively bind glycosylated proteins) to remove the membrane-associated (glycosylated) 
b-catenin fraction (Mukherjee et al. 2018). We observed that the level of total b-catenin 
started increasing monotonously 15 min after Wnt-3a stimulation until it reached a steady-
state at an elevated concentration at ~2 hours after Wnt exposure (Fig. 4A).  
We know that for any protein species, and so for total b-catenin: 
𝑅𝑎𝑡𝑒	  𝑜𝑓	  𝐴𝑐𝑐𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑜𝑛 = 𝑅𝑎𝑡𝑒	  𝑜𝑓	  𝑆𝑦𝑛𝑡ℎ𝑒𝑠𝑖𝑠 − 𝑅𝑎𝑡𝑒	  𝑜𝑓	  𝐷𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛      (1) 
Hernandez et al. had previously reported that the rate of synthesis of b-catenin does 
not change following Wnt-3a stimulation (Hernandez et al. 2012). The observed positive 
rate of accumulation of b-catenin thus implied that its rate of degradation decreased  
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Figure 4 – Dynamics of b-catenin in Presence of Wnt-3a: Figure showing the temporal 
change in concentrations of (A) cytosolic total b-catenin (B) whole-cell CK1-p-b-
catenin and (C) GSK3-p-b-catenin upon Wnt-3a addition at 0 hours. Each data point 
in the graph represent the mean (± 1 s.d) of three independent experimental repeats 
(n=3). 
initially, which led to the observed increase in b-catenin levels. However, rate of 
accumulation became zero at the new steady-state observed at the 2-hour mark, suggesting 
that the rate of b-catenin degradation recovered to equal the rate of synthesis at that point, 
i.e. the rate of degradation of total b-catenin at the 2-hour mark recovered in the cell to 
equal its rate of degradation before Wnt-3a stimulation. 
𝑅𝑎𝑡𝑒	  𝑜𝑓	  𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛9:;	  <=>?@ = 𝑅𝑎𝑡𝑒	  𝑜𝑓	  𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛9:A	  <=>?	                 (2) 
Next, we wanted to observe the changes in the levels of CK1-p-b-catenin and 
GSK3-p-b-catenin upon Wnt stimulation. In contrast to total b-catenin, there is no 
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consensus about the subcellular localization of the phosphorylated species of b-catenin. 
So, we proceeded to measure the temporal changes of these two post-translationally 
modified species of b-catenin in the whole-cell lysates (as the most general case). In case 
of CK1-p-b-catenin, we observed temporal trends similar to that of total b-catenin i.e., 
levels of CK1-p-b-catenin in the cell increased with time (starting at 30 mins instead of the 
observed 15 mins in case of total b-catenin earlier) before attaining a steady-state at a 
higher concentration, ~2 hours after Wnt stimulation (Fig. 4B). 
 
Figure 5 – Membrane Localization of Axin1 May Cause GSK3 inhibition: (A) 
Cumulative levels of newly-synthesized GSK3-p-b-catenin decrease while that of total 
b-catenin remain relatively unchanged in presence of canonical Wnt signaling. Input 
lanes represent whole-cell lysates of AHA-treated cells; Control lanes and Strep 
(streptavidin) lanes represent input lysates treated with DBCO-sulfo-biotin and 
subsequently pulled down with control agarose beads and streptavidin-conjugated 
beads respectively (B) Immunoprecipitation of Axin1 shows LRP6 co-
immunoprecipitating in the presence of Wnt-3a, suggesting membrane localization of 
Axin1 and destruction complex. Input lanes represent whole-cell lysates of cells; IgG 
and Axin1 lanes represent lysates immunoprecipitated with control Rabbit IgG 
antibody and anti-Axin1 IgG antibody respectively. 
In contrast, we found that the concentration of GSK3-p-b-catenin decreased 
initially (the minimum being at ~15-30-minute mark) and then recovered, reaching a new 
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steady-state that coincided in time with that of total and CK1-p-b-catenin i.e. at ~2 hours 
after Wnt stimulation (Fig. 4C). Now, this observation was inconsistent with inhibition 
happening solely at the downstream ubiquitination step (Mukherjee et al. 2018). As noted 
by Hernandez et al., inhibition of ubiquitination, but not of any other step in b-catenin 
degradation, would cause GSK3-p-b-catenin to continue to accumulate, much like total 
and CK1-p-b-catenin, until the ubiquitination flux, and hence the degradation flux, 
recovered their original values at a higher steady-state concentration of GSK3-p-b-catenin. 
Hence, the model proposed by Li et al. didn’t satisfactorily explain our preliminary 
observations regarding the GSK3-p-b-catenin minimum (Hernandez et al. 2012). 
The previous experiments showed what happens to the cell in presence of Wnt-3a 
relative to its initial steady-state. We proceeded to remove this background of previously 
present steady-state levels of proteins by measuring the concentrations of newly-
synthesized total, CK1-p- and GSK3-p-b-catenin levels immediately following Wnt-3a 
stimulation (Fig. 5A). This was done using BioOrthogonal Noncanonical Amino Acid 
Tagging or BONCAT (Dieterich et al. 2007). In BONCAT, we treated the cellular media 
with the methionine-substitute noncanonical amino acid, L-Azidohomoalanine (L-AHA) at 
the same time that we started the Wnt treatment. This resulted in proteins translated after 
the addition of Wnt to be selectively tagged with L-AHA. To analyze the cumulative 
population of newly synthesized proteins, we also treated the cells with the well-known 
proteasomal inhibitor MG132 to significantly decrease overall protein degradation in the 
cell, thus boosting the signal from these low levels of proteins. L-AHA contains an azide 
moiety which is highly amenable for use in azide-alkyne “click” cycloaddition. Leveraging 
this property of L-AHA, we then labeled the newly synthesized proteins with biotin and 
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isolated them from the lysate using Streptavidin-Agarose beads (Debets et al. 2010). The 
amounts of newly synthesized total-b-catenin (Fig. 5A, top) and CK1-p-b-catenin (data not 
shown) were relatively unchanged (as we had hypothesized) before and after Wnt 
treatment. We also observed significant levels of newly-synthesized GSK3-p-b-catenin in 
presence as well as in absence of Wnt-3a, but the levels were significantly lowered upon 
Wnt treatment (Fig. 5A, middle). The above observation is consistent with the partial 
inhibition of b-catenin phosphorylation upon Wnt-3a stimulation. Previous studies have 
shown conclusively that the binding of Wnt-3a to its cellular receptors results in destruction 
complexes relocating to the cellular membrane (to form “signalosomes”) (Bilic et al. 2007; 
Gerlach et al. 2018). We confirmed the above by observing that the cellular Wnt receptor 
LRP6 co-immunoprecipated with Axin1 upon Wnt-3a stimulation (Fig. 5B). Thus, we 
hypothesized that the relocalization of destruction complexes to the cellular membrane may 
be connected to the partial decrease in GSK3 phosphorylation, and thus in the partial loss 
of destruction complex activity upon Wnt-3a stimulation. 
To explore this hypothesis further, we monitored the changes in levels of non-
membrane-associated CK1-p-b-catenin and GSK3-p-b-catenin (i.e., the cytoplasmic and 
nuclear fraction) following Wnt stimulation like in the case of total b-catenin (Fig. 6A). As 
seen in Fig. 6B, the temporal trends for the non-membrane associated CK1-p-b-catenin and 
GSK3-p-b-catenin were very similar to their whole-cell counterparts. This evidence 
suggested that most of the phosphorylated b-catenin were not membrane associated. We 
confirmed this by further analyzing the membrane-associated proteins being pulled down 
with the Concanavalin A beads. In accordance with our previous observations, no  
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Figure 6 – Concentrations of Non-Membrane-Associated Phosphorylated b-catenin: 
(A) Figure shows change in concentrations of cytosolic and nuclear fractions of 
GSK3-p-b-catenin and CK1-p-b-catenin (B) Graphs co-plotting whole-cell (blue) and 
cytosolic and nuclear (orange) fractions of different forms of phosphorylated b-
catenin on the same graph. Each data point in the graph represent the mean (± 1 s.d) 
of three independent experimental repeats (n=3). 
significant levels of GSK3-p-b-catenin and CK1-p-b-catenin were pulled down in these 
membrane fractions (Fig. 7B). Taken together, these results indicated that an inhibition of 
the phosphorylation activity of the destruction complexes is correlated with the 
relocalization of these complexes to the membrane upon Wnt stimulation, with the residual 
phosphorylation activity coming primarily from the non-membrane associated (mainly 




Figure 7 – Subcellular Localization of Core Canonical Wnt proteins: Figures showing 
temporal change in concentrations of whole-cell (Lanes 1), cytosolic and nuclear 
(Lanes 2) and membrane-associated fractions (Lanes 3) of core canonical Wnt 
proteins obtained from incubating lysates with Concanavalin A-Sepharose 4B beads. 
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2.3.2   Investigating the biophysics of the destruction complex upon Wnt-3a stimulation 
As a natural next step, we wanted to investigate the underlying biophysical 
mechanism responsible for the inhibition described above. To do so, we had to design a 
strategy to probe the entire population of the destruction complexes. As suggested by Li et 
al., we proceeded to immuoprecipitate the limiting component of the destruction complex 
without perturbing its protein-protein interactions with the other components of the 
destruction complex (i.e. co-immunoprecipitation) (Li et al. 2012). However, we differed 
in a key way from Li et al. in that we chose to immunoprecipitate APC, and not Axin1, as 
in case of Li et al. This was in large parts due to multiple recent reports that APC levels are 
significantly lower than Axin1 levels in our cell line of choice, i.e. the HEK293T cell line, 
and thus is more likely to be the limiting component in the destruction complexes as 
opposed to the traditional view (Tan et al. 2012; Kitazawa et al. 2017).  Upon co-
immunoprecipitation, we measured the changes in concentrations of the major canonical 
Wnt proteins Axin1, GSK3-p-b-catenin and LRP6 being pulled down along with APC (Fig. 
8).  We immediately observed that there was a significant decrease (~56% or 0.56 times) 
in Axin1-APC interaction upon Wnt stimulation, similar to what Valvezan et al. observed 
in L cells upon Wnt stimulation (Fig. 8A and 8B) (Valvezan et al. 2012). We also observed 
an initial decrease in the concentration of co-immunoprecipitated GSK3-p-b-catenin, with 
no concomitant increase in co-immunoprecipitated LRP6 concentration (Fig. 8A).  
Levels of GSK3-p-b-catenin then recovered substantially by 1.5 hours after Wnt 




Figure 8 – Axin1 Dissociates from APC upon Wnt Signaling: Figure showing 
immunoprecipitation of APC. (A) Immunoblotting for key destruction complex 
components co-immunoprecipitating with APC. Input lanes represent whole-cell 
lysates of cells; IgG and APC lanes represent lysates immunoprecipitated with control 
Rabbit IgG antibody and anti-APC IgG antibody respectively. (B) Bar graph 
quantifying the decrease in Axin1-APC interaction. Bar represent the mean (± 1 s.d.) 
of five independent experimental repeats (n=5). ***p<0.05 from performing one-way 
(single-factor) ANOVA and post-hoc pairwise Tukey’s HSD test. 
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from our previous observations (Fig. 8A; middle). Li et al.’s co-immunoprecipitation 
studies with Axin1 conclusively showed that Axin1’s interactions with some of the other 
destruction complex components remained intact upon Wnt signaling. Taken together, 
these observations indicated that a decrease in Axin1-APC interaction, and thus a partial 
disassembly of destruction complexes upon Wnt stimulation results in an initial decrease 
in the rate of GSK3 phosphorylation and an inhibition of degradation of b-catenin.  
Collectively, we see that a fraction of the destruction complexes relocates to the 
membrane while the remaining destruction complexes remain in the cytosol. The 
membrane translocation of destruction complexes is correlated with their partial 
disassembly and the inhibition of their activity leading to the inhibition of b-catenin 
degradation. The cytosolic destruction complexes remain structurally intact and active.  
The decrease in the levels of active destruction complexes results in an increase in the 
intracellular concentration of b-catenin due to an initial decrease in the rate of b-catenin 
degradation. The accumulating cytosolic b-catenin then causes an increase in the rate of b-
catenin phosphorylation by the active destruction complexes via the principal of “mass 
action” which continues until the rate of degradation once again equals its rate of synthesis. 
This restores the b-catenin flux through the destruction complexes to its original value, 
thus leading to the observed new steady-state following Wnt stimulation (Mukherjee et al. 
2018). 
2.3.3   Kinetic modeling of b-catenin modifications in canonical Wnt signaling 
We proceeded to kinetically model the dynamics of intracellular b-catenin 
modifications to further validate our hypothesis. In the schematic depicted in Fig. 9A, B0, 
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B1, B2, and B3 represent unphosphorylated b-catenin, CK1a-phosphorylated b-catenin, 
GSK3-phosphorylated b-catenin, and ubiquitinated b-catenin respectively (Hernandez et 
al. 2012).   
 
Figure 9 – Kinetic Modeling of b-catenin Dynamics: (A) Schematic showing sequence 
of reversible kinetic reaction equations used to model cytosolic b-catenin 
modifications. Graphs showing simulated curves for best fits of (B) total b-catenin (C) 
GSK3-p-b-catenin and (D) CK1-p-b-catenin upon decreasing k1, k2 and k3 by 56%. 
Experimental data points are shown in respective figures for comparison. 
S represents the rate of synthesis of b-catenin 
[Bi] denote the concentrations of the post-translationally modified b-catenin for i = 1, 2, 3  
kdeg denotes the rate of proteasomal degradation, and  
kj denote the forward and reverse rate constants depicting phosphorylation, 
dephosphorylation, ubiquitination and deubiquitination, for j = ±1, ±2, ±3. 
Based on the above notations, the equations governing the kinetics of phosphorylation and 




= 𝑆 − 𝑘H[𝐵A] + 𝑘KH[𝐵H]                                            (3) 
B[DL]
B9
= 𝑘H[𝐵A] − 𝑘; + 𝑘KH [𝐵H] + 𝑘K;[𝐵;]    (4) 
B[DM]
B9
= 𝑘;[𝐵H] − 𝑘N + 𝑘K; [𝐵;] +	  𝑘KN[𝐵N]   (5) 
B[DO]
B9
= 𝑘N𝐵; − (𝑘BQR + 𝑘KN)[𝐵N]    (6) 
In the above equations, the rate of phosphorylation by CK1, GSK3 and b-TrCP E3 
ligases were assumed to be governed by the Michaelis-Menten kinetics for low substrate 
concentrations relative to the Michaelis constant (KM1); 
k1 = (kcat1/KM1)[DC]                                                               (7) 
where kcat1 is the intrinsic catalytic rate of CK1 in the destruction complex,  
[DC] is the destruction complex concentration.  
First, we applied the above model to our results to predict whether the destruction 
complex activity was  
a.   “processive” i.e. b-catenin undergoes a series of phosphorylations within the 
destruction complex before being released from it, or   
b.   “distributive” i.e. b-catenin can dissociate from the complex in between sequential 
steps.  
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The generally accepted view, as suggested in Hernandez et al., is that the destruction 
complex activity is “processive” (Hernandez et al. 2012). However, our results were 
inconsistent with this assertion. 
Based on Equation (1) and (2) in Page 21-22, we can say that 
𝑆 = 	  𝑘BQR[𝐵N]9:A	  <=>?@                                             (8) 
𝑆 = 	  𝑘BQR[𝐵N]9:;	  <=>?@                                             (9) 
and S remains unchanged. 
Hence, combining (8) and (9) 
𝑘BQR[𝐵N]9:A	  <=>?@ = 	  𝑘BQR[𝐵N]9:;	  <=>?@                (10) 
Since, proteasomal degradation remains unchanged due to canonical Wnt signaling, 
𝑘BQR remains unchanged over time. 
So, [𝐵N]9:A	  <=>?@ = 	   [𝐵N]9:;	  <=>?@                        (11) 
In other words, the concentration of ubiquitinated b-catenin is the same at both the steady-
states, regardless of whether the destruction complex is processive or distributive. 
Next, we see that at the steady-states t = 0 hours and t = 2 hours, LHS of equation (6) is 
equal to zero, which can be written as, 
0 = 𝑘N[𝐵;]9:A − (𝑘BQR + 𝑘KN)[𝐵N]9:A               (12) 
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0 = 𝑘N[𝐵;]9:; − (𝑘BQR + 𝑘KN)[𝐵N]9:;         (13) 
Combining (11), (12) and (13), seeing that 𝑘BQR	  𝑎𝑛𝑑	  𝑘KN are constant, we deduce that, 
𝑘N[𝐵;]9:A = 	  𝑘N[𝐵;]9:;                                 (14) 
At this step, let’s assume that the destruction complex is “processive”. That suggests that 
ubiquitination can only happen inside the destruction complex. Since b-TrCP E3 ligase can 
be assumed to be governed by the Michelis-Menten kinetics, 
𝑘N = 	  𝑘UV9N	  at both t = 0 hours and t = 2 hours steady-states         (15) 
Equation (14) and (15) thus asserts that, [𝐵;]9:A = 	   [𝐵;]9:;         (16)       
i.e., the concentration of GSK3-phosphorylated b-catenin must be the same at both the 
steady-states which is not consistent with our observations in Fig. 4C and Fig. 5A . 
If we follow a similar methodology, we can deduce that in the “processive” case, the 
concentration of CK1-phosphorylated and GSK3-phosphorylated-b-catenin must return to 
their initial steady-state value at 2 hours after Wnt-3a stimulation, which is completely 
contradictory to what we observed in our experiments. Hence, our model infers that b-
catenin’s interaction with the destruction complex is “distributive” (Mukherjee et al. 2018). 
In our proposed “distributive” model, the decrease in the number of active destruction 
complexes due to the canonical Wnt signal causes a decrease in magnitudes of the rate 
constants for phosphorylation and ubiquitination i.e. in k1, k2, and k3 (Equation 7). We 
argued that the percentage of “deactivated” destruction complexes due to membrane 
relocation was the same as the percentage decrease in Axin1-APC interaction (Fig. 8B). 
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Figure 10 – Inhibiting Different Steps in Kinetic Model of b-catenin Dynamics: 
Graphs showing simulated GSK3-p-b-catenin curves obtained upon (A) decreasing 
ubiquitination (k3) only, (B) GSK3-phosphorylation (k2) only, or (C) CK1-
phosphorylation and GSK3-phosphorylation only (k1 and k2) (all by 56%). 
Experimental data points are shown in each graph for comparison. 
Logically, it followed that the fraction of active destruction complexes, with intact 
Axin1-APC interaction, was 0.44 times the initial destruction complex concentration (Fig. 
8B). When we decreased the value of the rate constants k1, k2, and k3 to 0.44 times their 
value before Wnt addition, the b-catenin concentrations obtained by numerical integration 
of the equations (3) – (6) closely matched the experimental results (Fig. 9B-D).   
In contrast, if only ubiquitination was inhibited (as proposed by Li et al.), the kinetic 
model simulations did not show a dip in the concentration of GSK-p-b-catenin (Fig. 10A). 
If only phosphorylation was inhibited, but not ubiquitination (as proposed by Hernandez 
et al.), then the GSK3-p-b-catenin level at the new steady state recovered to its initial value, 
but didn’t exceed it, which contradicted our experimental results (Fig. 10B and Fig. 10C). 
The above scenario suggested that all three b-catenin post-translational modification steps 
(both phosphorylation and the ubiquitination) are partially inhibited. To confirm that 
ubiquitination is indeed inhibited, we treated the cells with MG132 to promote a build-up 
of the usually short-lived ubiquitinated b-catenin. Upon Wnt-3a stimulation, we clearly 
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Figure 11 – Monitoring Ubiquitination of GSK3-p-b-catenin: Immunoblots showing 
lysates probed with anti-GSK3-p-b-catenin and anti-a-tubulin antibody (internal 
control) respectively. The ubiquitination of b-catenin is reflected in the intensity of 
the smear in Lanes 1, 2 and 3 above the indicated GSK3-p-b-catenin band. Lane 1 
and Lane 3 have equal loading of GSK3-p-b-catenin. 
observed a significant decrease in the concentration of ubiquitinated b-catenin that showed 
up as a smear in the GSK3-p-b-catenin immunoblots (Fig. 11). 
In summation, 
1.   The canonical Wnt signal results in 56% of the destruction complexes relocating to 
the plasma membrane, where they associate with the Fzd-LRP6 heterodimeric 
complex.  
2.   This relocation leads to the partial disassembly of the destruction complex due to 
the dissociation of APC from Axin1, which inhibits the CK1 and GSK3 
phosphorylation of b-catenin.    
3.   The remaining 44% of the destruction complexes remain structurally intact and 
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efficiently degrade b-catenin in the cytoplasm. However, the overall decrease in the 
level of active destruction complexes initially decreases the rate of degradation of 
b-catenin.   
4.   Consequently, free b-catenin accumulates in the cytosol, until “mass action” drives 
a recovery of the rate of degradation of b-catenin at an elevated steady-state level 
of b-catenin (at 2 hours after Wnt stimulation) by restoring the degradation flux 




Figure 12 – Schematic Showing Proposed Model of Canonical Wnt Signaling: In (A) 
Wnt OFF cells, destruction complexes in the cytosol remain active and efficiently 
degrade cytosolic b-catenin. In (B) Wnt ON cells, a fraction of the destruction 
complexes relocates to the plasma membrane leading to their partial disassembly, 
thus inhibiting their ability to degrade b-catenin. 
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2.4   Discussions 
2.4.1   Improving the quality of fit of theoretical model to experimental observations 
We have presented a combined experimental and computational model to describe 
the transduction of the canonical Wnt signal through the cytosol. However, there is scope 
to further improve the theoretical fit of our kinetic model to our experimental observations. 
One aspect would involve taking into account the diffusion of the Wnt ligand through the 
extracellular medium. In culture, the Wnt ligand binds to different cells at different times, 
which leads to a heterogeneity among the cell populations regarding the initiation of 
assembly of the Fzd-LRP6 complexes. It is also possible that assuming Michaelis-Menten 
kinetics at low substrate concentrations may be too simplistic to yield a highly accurate fit. 
One could explore implementing other kinetic equations to simulate the enzymatic 
reactions described in the model and investigating the subsequent effects. 
2.4.2   Generalizing our model to other cell types and culture conditions 
As shown by Tan et al. (Tan et al. 2013), the expression levels of the crucial protein 
components of the Wnt pathway vary quite significantly among cell lines. This variation 
can have implications on all aspects of the Wnt pathway described above, including the 
nature of b-catenin and destruction complex interaction at different post-translational 
modification steps as well as the extent of inhibition of b-catenin degradation. To that end, 
our approach can be easily translated to different cell types to systematically investigate 
each of these phenomena and monitor the variations of Wnt transduction cascade across 
cell lines. To do so, one can start by confirming that the temporal trends of different post-
translationally modified b-catenin species remain unchanged in different cell types. Next, 
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one can set up a series of end-point experiments to compare the levels of different b-catenin 
species at the two steady-states described above. The normalized concentration values can 
be evaluated using the kinetic model to derive conclusions about the nature of the rate-
limiting steps and the underlying biophysical phenomena of the canonical Wnt signaling 
cascade.  
Such a comparative study can also be extended to different culture conditions. For 
example, hypoxia has been hypothesized to be a key microenvironmental factor capable of 
influencing the proliferation and differentiation of stem cells in vivo (Abdollahi et al. 2011; 
Hawkins et al. 2013). Hypoxia has been shown to influence canonical Wnt signaling in 
several different cell types including stem cells and cancer cells (Xu et al. 2017). However, 
there have been multiple conflicting reports regarding the exact nature of such an influence 
(Verras et al. 2008; Varella-Nallar et al. 2014).  Monitoring the intracellular concentrations 
of key Wnt proteins under different starting culture conditions using our approach may 
help characterize how various microenvironmental factors modulate the canonical Wnt 




CHAPTER 3.   SYNTHETIC MULTIVALENT AGONISTS FOR 
CANONICAL WNT SIGNALING ACTIVATION 
3.1   Background 
Our understanding of the role of canonical Wnt signaling in development and disease 
is ever increasing. While 19 mammalian Wnt genes have been discovered till date, the 
study of their respective protein products has moved at a painstakingly slow pace (Willert 
and Nusse 2012). Very little was known about the structure of Wnt proteins until Janda et 
al. published the crystal structure of the Xenopus Wnt8 bound to the cysteine-rich domain 
(CRD) of the mouse Frizzled8 (Fzd8) receptor (Willert and Nusse 2012; Janda et al. 2012). 
Moreover, there is significant cross-reactivity between the different Wnt proteins and the 
10 different Frizzled (Fzd) surface receptors. This cross-reactivity has further hindered the 
discovery and attribution of specific biological functions to the different Fzd-Wnt 
interactions (Clevers and Nusse 2012). 
The major roadblock in investigating the role of Wnt proteins in key bioprocesses 
and their downstream interactions with receptor proteins, is the immense difficulty 
associated with the purification of these Wnt proteins, which is primarily due to the myriad 
post-translational modifications that a Wnt protein must go through for its efficient 
secretion and activity (Willert and Nusse 2012). As a case study, we note that Wnt-3a 
contains two N-linked glycosylation sites and one palmitoylation site among its amino acid 
residues.  Mutations in the glycosylation sites impair the secretion of the Wnt-3a protein 
from mammalian cells, suggesting that glycosylation is essential for the proper folding 
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and/or the subsequent secretion of this protein (Komekado et al. 2007; Kurayoshi et al. 
2007). However, multiple Wnt proteins have been shown to be active even in the absence 
of glycosylation (Mason et al. 1992). 
 In contrast, acylation has been shown to be critical for Wnt activity. The crystal 
structure of Wnt8 bound to Fzd8 reported in 2012 showed that the palmitoleic acid lipid 
group at the conserved Ser187 residue in Wnt8 (Ser209 for Wnt-3a) projects into a deep 
groove in the CRD of Fzd8, thus underlining the importance of lipidation for maintaining 
the ability of Wnt proteins to bind to the Fzd receptors (Janda et al. 2012). Indeed, mutation 
of this serine residue results in impaired secretion and a complete loss of activity of the 
Wnt proteins (Takada et al. 2006; Komekado et al. 2007).  
 These necessary post-translational modifications, in turn, make the Wnt proteins 
highly hydrophobic and water insoluble.  Thus, the purification of these proteins requires 
extensive use of detergents in the workflow. These properties also limit the use of Wnt as 
potential therapeutic agents and hinder the study of the molecular mechanisms underlying 
Wnt signaling (Willert and Nusse 2012; Janda et al. 2017). So, water-soluble surrogate 
molecules which mimic the functions of these Wnt proteins could be of immense 
importance in advancing our understanding of Wnt-driven processes. 
In 2017, Janda et al. reported the first molecules of this kind. They designed water-
soluble Fzd-LRP5/6 heterodimerizers which elicited a signature b-catenin response, much 
like the canonical Wnt-3a molecule (Janda et al. 2017). In this thesis, we independently 
developed synthetic heterodimers which bound specifically to the Wnt receptors while 
being orthogonal to all other cellular receptors.  These heterodimers activated the canonical 
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Wnt signaling cascade and closely mimicked the endogenous signaling dynamics. We also 
demonstrated that the covalent chemistry used in the process is amenable to the “one-pot 
synthesis” of these heterodimers. Additionally, we also outlined a strategy to increase the 
potency of these synthetic agonists, which will promote its scalability and decrease the 
overall cost of production of these molecules, thus potentially aiding their applications in 
multiple Wnt-driven bioprocessing workflows. 
3.2   Material and Methods 
Plasmids 
a.   The 7x TFP Wnt luciferase reporter (Fuerer and Nusse 2010) was constructed with 
a pVitro2-MCS vector with a hygromycin resistance for bacterial transformation. 
In the first cloning site (MCS-1), the ferritin promoter was removed and replaced 
with a minimal promoter (minP) and the firefly luciferase nucleotide sequence was 
inserted downstream of minP. The CMV enhancer sequence was deleted and 7 b-
catenin binding TCF enhancer sites were inserted upstream of the minP to make 
the reporter responsive to an increase in b-catenin concentration in the nucleus. The 
minP and the 7x TCF binding site sequences were custom-synthesized and inserted 
into the pVitro2-MCS vector by Gene Universal. 
b.   The Frizzled Fab (Fzd-Fab) and LRP6 Fabs (LRP6-Fab) (clones 6475 and 8168) 
were engineered from Frizzled antibody and LRP6 antibody sequences obtained 
from Gurney and Jenkins et al. respectively. The expression plasmids were 
constructed by inserting the respective Fab light chain and heavy chain sequences 
into a TGEX vector obtained from Antibody Design Labs. The TGEX vectors code 
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for the constant region of the human IgG heavy chain CH1 region with a C-term 6x 
His tag and the human kappa light chain CH1 region. The sequence for a SpyTag 
was inserted into the C-terminus of the heavy chain of the Fzd-Fab. The SpyCatcher 
sequence was inserted into the C-terminus of the LRP6 following 3x(GGGGS) 
linkers. All plasmids were custom-synthesized and cloned into the TGEX vector by 
Gene Universal. 
Transfection of 293F Cells for Obtaining Secreted Proteins 
45 mL 293F (Thermo Scientific) mammalian cell cultures were grown up to a density of 
2.9x106 cells per mL in a 125-mL Erlenmeyer flask. Cultures for Fab expression were 
transfected with the heavy-chain and light-chain coding plasmids in a 1:2 w/w ratio. This 
plasmid ratio ensured that the 6xHis-Tag containing heavy chains were present in excess 
and were consumed in the Fab recombination as the limiting component. Transfection was 
performed using the ExpiFectamine (Thermo Scientific) transfection reagent according to 
the manufacturer’s recommendation. Recommended doses of transfection enhancers were 
added to the culture 20-24 hours after initial addition of transfection reagents. Post 
transfection, cells were incubated for 6 days and the Expi293F (Thermo Scientific) 
supernantant media harvested afterward to proceed in the workflow. 
ELISA to Validate Binding of Ligands to Antigens 
0.1 µg of commercial LRP6 ectodomain fused to a human IgG Fc region (LRP6-Fc) and 
Frizzled 2 (Fzd2) CRD fused to a human IgG Fc region (Fzd-Fc) were diluted in 100 µL 
of carbonate buffer (pH 9.6). The above antigens were used to coat a Maxisorp 96-well 
plate (Thermo Scientific) overnight at 4°C. After this step, each well was blocked using 
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5% BSA solution in TBST (TBS containing 0.05% Tween-20) for 1 hour at room 
temperature. The blocked wells were then incubated with the respective primary 
antibodies/Fabs and then by the respective secondary anti-human/anti-His antibodies 
(Jackson Immunoresearch; Thermo Scientific) diluted in 5% BSA solution in TBST at a 
concentration recommended by the manufacturer. All wells were washed thoroughly with 
200 µL of TBST in between incubation steps. Finally, the wells were incubated with 100 
µL TMB (Thermo Scientific) solution for 15 minutes followed by the addition of 100 µL 
Stop solution. Next, the plate was imaged at 450-nm using the BioTek Synergy plate reader 
in the Biopolymer Characterization Core in EBB. 
Purifying Fzd Fab-LRP6 Fab Heterodimers 
The supernatant containing unreacted Fzd Fab, LRP6 Fab and the Fzd Fab-LRP6 Fab 
heterodimers was first purified using the IMAC protocol using Ni-NTA (Thermo 
Scientific) agarose beads/resin in 30 mL columns.  The Ni-NTA beads specifically bound 
to the 6xHis Tag on these proteins. Each Ni-NTA column was first equilibrated with 20 
column volumes of equilibration (50 mM Phosphate, 500 mM NaCl, 25 mM imidazole, 
pH 8.0). The supernatant was then passed through the column and the flow through 
discarded. The column was then washed using 50 mM imidazole buffer (pH 8.0) once to 
get rid of non-specific protein binding in the beads/resin and the flow through was 
collected. The protein of interest was then eluted with ~400 mM imidazole (pH 8.0) buffer 
in 2 mL fractions and all the fractions were collected. 
The eluted proteins were then concentrated down to ~1 mL by centrifuging at 7000g in 
Amicon 10kDa MWCO 15 mL spin filters (EMD Millipore). The 1 mL eluate was then 
 46 
purified in a HiLoad Superdex 200 column loaded on an AKTA Pure chromatography 
system (GE Healthcare) using the principles of size-exclusion chromatography. All 
fractions were collected in PBS buffer using the fraction collector. The fractions 
corresponding to the peaks in A280 (absorbance at 280 nm) and A205 (absorbance at 205 
nm) curves were run on an SDS-PAGE gel and analyzed for purity using Coomassie 
Brilliant Blue Staining or Silver Staining. All fractions with satisfactory purity (>80%) of 
dimers (showing up at ~110 kDa) were pooled and concentrated again in an Amicon 10kDa 
MWCO 15 mL spin filter. The purified proteins were then aliquoted and stored. For short-
term use, purified heterodimers were stored in PBS containing >40% glycerol at -20°C. 
For long-term storage, purified fractions were frozen in -80°C in PBS containing >40% 
glycerol. 
Luciferase Assay to Verify Activation of Canonical Wnt Signaling 
293T cells were plated on a 6-well plate coated with poly-L-lysine and grown up to ~80% 
confluency. The cells were then transfected with the 7x TFP reporter plasmid, trypsinized 
24 hours after transfection (0.25% Trypsin-EDTA, Thermo Scientific), re-plated in a 96-
well plate (Corning) coated with poly-L-lysine (Sigma-Aldrich). Transfected cells were 
then treated with different concentrations of heterodimers and Wnt-3a diluted in D-10 
media. The final concentrations of treatment ranged from 5 nM to 25 nM at 5 nM intervals. 
Each treatment was done in triplicates. After 24 hours of treatment, cells were lysed in a 
passive lysis buffer (Promega) and centrifuged in the 96-well plate (Corning) at 2000g for 
10 minutes to remove debris from the cell lysate. The cleared cell lysates were then 
transferred to an opaque white-walled 96-well plate (Corning). Luminescence signal was 
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then measured from each well in a BioTek Synergy plate reader immediately following the 
addition of the Luciferase Assay Reagent (Promega). 
3.3   Results 
3.3.1   Expressing Frizzled-binding and LRP6-binding Fabs 
To begin, we wanted to verify whether we could obtain Fabs that are capable of 
potently binding to Frizzled and LRP6 proteins. Full-length sequences of Frizzled- and 
LRP6-binding antibodies were obtained from Gurney and Jenkins et al. respectively 
(Jenkins et al. 2014; Gurney 2016). For the expression of each Fab, two separate plasmids 
were designed, one coding for the heavy chain and the other coding for the light chain. In 
both cases, the sequences corresponding to the variable regions obtained from the patents 
were inserted into TGEX-FH and TGEX-LC vectors for expressing the heavy and light 
chains respectively. TGEX-FH also encodes a 6xHis tag at the C-terminus of the CH1 
region. The Fabs were then expressed using the 293F mammalian protein expression 
system by co-transfecting the plasmids encoding for both the heavy and light chains in a 
1:2 w/w ratio in 30-45 mL cell cultures. The light chain plasmid was always transfected in 
excess to ensure that the heavy chain was effectively the “limiting” reactant in the heavy 
and light chain combination process to form the Fab. Upon expression and combination, 
the Fabs were purified using the principles of affinity chromatography in a Ni-NTA 
column. Since the heavy chain encoded for a 6xHis tag and was the limiting reactant, we 
got highly pure Fabs from this round of Ni-NTA purification. Next, we further purified the 
individual Fabs using size-exclusion chromatography by passing them through a HiLoad 
Superdex 200 column to obtain highly pure fractions. These fractions were analysed on a 
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4-12% Bis-Tris Gel using SDS-PAGE Gel electrophoresis via Coomassie Brilliant Blue 
staining. Only the highly pure fractions were pooled, concentrated, and separately run on 
another gel to check for purity. We proceeded with the purified Fabs only when the purity 
was ~90% or above (Fig. 13). 
 
Figure 13 – Coomassie Blue Staining for Frizzled and LRP6 Ligands: Frizzled (Fzd) 
ligands (Fzd MAb and Fzd Fab) and LRP6 ligands (6475 Fab and 8168 Fab) imaged 
after SDS-Gel Electrophoresis on a 4-12% Bis-Tris Gel and subsequent Coomassie 
Brilliant Blue staining. The left-most lane represents the PageRuler Plus Protein 
Ladder. 
To test whether the purified Fabs were functional, we performed an ELISA to 
quantify the binding of the Fabs to their respective antigens. We coated 96-well plates with 
pure recombinant Frizzled and LRP6 proteins with a fused human IgG Fc region diluted in 
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carbonate buffer (pH 9.6). The Frizzled-binding Fab (Fzd-Fab) and two separate clones 
(clone# 6475 and 8168) of LRP6-binding Fabs (LRP6-Fab) were found to bind robustly to 
their corresponding antigens (Fig. 14A). To further quantify the in vitro activity of the  
 
Figure 14 – Characterizing the Frizzled (Fzd-Fab) and LRP6 (LRP6-Fab-6475 and 
LRP6-Fab-8168) ligands: (A) ELISA showing binding of Fzd-Fab and LRP6-Fabs 
(6475 and 8168) to their respective antigens; Frizzled cysteine-rich domain (Fzd CRD) 
and LRP6 ectodomain (LRP6 ecto) respectively, both fused to a human IgG-Fc 
region. **p<0.05 from performing one-way (single-factor) ANOVA and post-hoc 
pairwise Tukey’s HSD test (n=3 replicates). (B) Luciferase assay showing LRP6 Fabs 
blocking Wnt signal transduction in presence of Wnt-3a at different doses of Fabs. 
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LRP6-Fabs, we attempted to block Wnt signaling by treating 7TFP reporter-transfected 
293T cells with LRP6-Fabs. We observed that both clones of LRP6-Fabs blocked Wnt 
signal transduction and the extents of inhibition were proportional to the dose of LRP6-
Fab used in the treatment (Fig. 14B). 
3.3.2   Strategy to generate anti-Fzd-LRP6 heterodimers via SpyTag-SpyCatcher 
chemistry 
To generate the heterodimer composed of Fzd-Fab and LRP6-Fab monomers, we 
used the SpyTag-SpyCatcher protein coupling system. The SpyTag and SpyCatcher system 
was developed by Zakeri et al. by engineering a bacterial adhesin protein (Zakeri et al. 
2012). SpyTag is a short peptide which spontaneously forms a covalent isopeptide bond 
when it encounters its protein partner, SpyCatcher.  
In our case, we decided to insert the sequence for the short SpyTag on the heavy 
chain of the Fzd-Fab (Fzd-Fab-SpyTag) and the SpyCatcher on the light chain of the LRP6-
Fabs (clones 6475 and 8168) (LRP6-Fab-SpyCatcher) (Fig. 15A). To ensure proper folding 
of the SpyCatcher and the LRP6-Fab, we inserted a 3x(GGGGS) flexible linker between 
the C-terminus of the light chain of the LRP6-Fab and the SpyCatcher sequence (Fig. 15A). 
To confirm that our engineered Fabs retained their activity, we expressed and purified the 
individual monomers and performed another ELISA along the lines of the one mentioned 
in 3.3.1. We found substantial binding for all the fusion proteins (Fig. 15B). 
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Figure 15 – Validating Activity of Fzd-Fab-SpyTag and LRP6-Fab-SpyCatcher 
fusion proteins: (A) Schematic showing proposed strategy of anti-Fzd-LRP6 Fab 
heterodimer formation. ELISA showing the binding of (B) Fzd-Fab-SpyTag and (C) 
LRP6-Fab-SpyCatcher fusions to their respective antigens. Each data point 
represents mean (± 1 s.d.) of 10 replicates (n=10). **p<0.05 by performing Kruskal-
Wallis nonparametric test and post-hoc pairwise Dunn’s multiple comparisons test. 
ns = not statistically significant. 
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3.3.3   Generating anti-Fzd-LRP6 heterodimers via “one-pot” reaction 
The Fzd-Fab-SpyTag and the LRP6-Fab-SpyCatcher fusion proteins were 
expressed using the Expi293F protein expression system. Seven days after transfection of 
the plasmids, the 293F cell cultures were centrifuged and the supernatants analysed for the 
respective protein levels. The analysis was done by probing the supernatant using a primary 
mouse anti-6xHis-tag antibody in a dot-blot or a western blot. The bands were quantified 
and the Fzd-Fab-SpyTag and LRP6-Fab-SpyCatcher supernatants were mixed in ~1:1 
molar stoichiometric ratios. The required volumes of supernatants were mixed in a 125-
mL Erlenmeyer flask and incubated with constant shaking at 37°C for 3 hours. Reacting 
the fusion proteins in the already-optimized 293F medium minimized protein loss due to 
degradation and the extra incubation step ensured a relatively high conversion of reactants 
to the heterodimer product (Fig. 16A).  
The resulting product-reactant mixture was then dialyzed overnight in PBS at 4°C. 
The dialyzed mixture was then affinity-purified on a Ni-NTA column and analysed using 
SDS-Gel Electrophoresis and Coomassie Brilliant Blue staining. As expected, the reaction 
mixture showed three prominent protein bands on the Bis-Tris gel, corresponding to the 
heterodimer product (~110 kDa band of the PageRuler Plus Protein ladder), the unreacted 
LRP6-Fab-SpyCatcher (~60 kDa) and the unreacted Fzd-Fab-SpyTag (~50 kDa). Next, we 
further purified the Ni-NTA elution using size-exclusion chromatography (SEC) to 
separate the ~110 kDa desired heterodimer from the smaller unreacted fusion proteins. The 
dilute fractions obtained from SEC were analysed again via SDS-PAGE Gel 
Electrophoresis and Coomassie Blue staining. 
 53 
 
Figure 16 – Generating anti-Fzd-LRP6-Fab Heterodimers from Individual 
Monomers: (A) Schematic showing proposed “one-pot” strategy of generating anti-
Fzd-LRP6-Fab heterodimers without intermediate purification. (B) Gel Image 
showing the formation of pure heterodimer 8168 (Lane 3) from the Fzd-Fab-SpyTag 
(Lane 1) and LRP6-Fab-Spycatcher (Lane 2) fusions. 
The highly pure fractions, mostly devoid of any unreacted LRP6-Fab-SpyCatcher, 
Fzd-Fab-SpyTag and partially degraded heterodimers, were pooled, concentrated using a 
centrifuge filter, and quantified using either a BCA or a microBCA assay. Hereon, we refer  
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Figure 17 – Characterizing Activity of Heterodimer 8168: A) ELISA showing the 
avidity of Heterodimer 8168 towards both Frizzled and LRP6. Each data point 
represents the mean (± 1 s.d.) of 10 replicates (n=10). **p<0.05 by Kruskal-Wallis 
nonparametric test and post-hoc pairwise Dunn’s multiple comparisons test. B) 
Luciferase assay showing activation of Wnt signaling by Heterodimer 8168. **p<0.05 
by one-way (single-factor) ANOVA followed by post-hoc pairwise Tukey’s HSD test. 
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to the individual heterodimers as “heterodimer 6475” or “heterodimer 8168” based on the 
clone of LRP6-Fab used to synthesize each one (Fig. 16B). 
3.3.4   Activation of canonical Wnt signaling by Fzd-LRP6 Fab heterodimers 
As a preliminary check, we wanted to test the ability of heterodimer 8168 to bind 
to both Frizzled and LRP6. As is evident from Figure 17, we observed heterodimer 8168 
binding robustly to both Frizzled and LRP6 with comparable avidity (Fig. 17A). 
To check activation of canonical Wnt signaling, 7x TFP-luciferase reporter-
transfected 293T cells were treated with 15 nM of purified heterodimer 8168. The 
luciferase signal, which corresponded to the level of canonical Wnt signal transduction 
from the heterodimer 8168-treated samples, was comparable to that of samples treated with 
Wnt-3a at a similar concentration, indicating robust activation of canonical Wnt signaling 
by heterodimer 8168. In contrast, the individual monomers and an orthogonal Fab-dimer 
did not show any elevation of luciferase signal (Fig. 17B).  
To characterize heterodimer 8168 further, we treated the 7x TFP reporter-
transfected 293T cells with various doses of Wnt-3a and heterodimer 8168. Based on our 
preliminary experiments, we observed that heterodimer 8168 was more potent than Wnt-
3a at lower doses (i.e. 5 nM and 10 nM) in activating the Wnt signaling pathway (Fig. 18). 
However, the level of signaling induced by heterodimer 8168 stagnated relative to Wnt-3a 
at higher concentrations of the ligands (i.e. 15 nM – 25 nM) (Fig. 18). Multiple independent 
biological repeats of the above experiment are underway to test the statistical significance 
of the phenomena. Qualitatively, we observed that the potency of heterodimer 8168 was 
comparable to wild-type Wnt-3a at various doses (Fig. 18). 
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Figure 18 – Preliminary Dose-Dependent Activation of Wnt-responsive 7x TFP 
Reporter: Both Wnt-3a and heterodimer 8168 robustly activate canonical Wnt 
signaling at the indicated doses. Each data point represents the mean of three 
technical replicates (mean ± 1 s.d.). 
To conclude, 
1.   We established a robust protocol to synthesize potent heterodimers capable of 
binding to Frizzled and LRP6. 
2.   The protocol is effectively one-pot and can be completed within 48 hours of 
harvesting cell cultures expressing unreacted monomeric Fab-fusions. 
3.   Heterodimers generated from this protocol were active and capable of triggering 
the endogenous canonical Wnt signaling pathway.  
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3.4   Discussions 
3.4.1   Potential advantages of Fab-based heterodimers 
The strategy described above to generate Fab-based heterodimers e.g. heterodimer 
8168, can potentially have several advantages over the natural and/or single-chain ligand-
based surrogate Wnt agonists described in Janda et al. (Janda et al. 2017). Firstly, the 
workflow to generate highly specific Fabs with relatively low non-specific interactions has 
been well-established in this industry. Hence, our approach can be translated relatively 
easily to generate heterodimers that can dimerize or oligomerize other receptor pairs 
specifically. Finding specific natural ligands to these receptors, with low levels of non-
specific side effects, can be a far more daunting prospect. Secondly, tuning the potency of 
these agonists via multivalency can also be achieved relatively easily in the case of the 
heterodimers described earlier in this chapter. It is relatively simple to introduce 
recombinant tags, such as AviTag, to our heterodimers which can subsequently be used to 
conjugate them to rigid or flexible multivalent scaffolds to increase their potency. Lastly, 
a natural ligand-based agonist design may not be feasible to activate other signaling 
pathways that involve receptor heterodimerization. Some such receptors may be “orphan” 
receptors with no known natural ligand, thus making it difficult to implement the strategy 
described in Janda et al. In contrast, we can proceed by generating antibodies, and 
subsequently Fabs, against such orphan receptors to design and develop potent synthetic 
agonists to activate diverse signaling networks. 
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3.4.2   Increased potency of heterodimer at low concentrations 
There are a number of possible explanations for the observed higher potency of the 
heterodimer 8168 compared to Wnt-3a at doses between 0 nM – 15 nM. One reason may 
be that the individual monomers, and hence the heterodimer, bind with a higher affinity 
(avidity, in case of the dimer) towards Frizzled and LRP6 than wild-type Wnt-3a. 
Alternatively, this increased potency may be because the LRP6-Fab monomer (clone 8168) 
binds to the b-propeller domains 1 and 2 (E1E2) of LRP6 in contrast to Wnt-3a, which 
binds to the b-propeller domains 3 and 4 (E3E4). The different binding sites may result in 
a change in the extent of receptor oligomerization which may result in the observed 
difference in the level of Wnt activation. Further investigation is needed to resolve which 
of the above two scenarios are relevant in this case. 
3.4.3   Implications for differential binding kinetics of the heterodimer 
As described in Chapter 2, the interaction between the Fzd-LRP6 receptor complex and 
Axin1 plays a key role in transducing the canonical Wnt pathway. The formation of the 
Fzd-LRP6 heterodimeric complex is directly related to the binding dynamics of the 
extracellular Wnt/surrogate Wnt ligand to these membrane receptors. To accurately 
investigate the influence of such binding dynamics, monitoring the changes in levels of 
intracellular core Wnt proteins upon heterodimer 8168 treatment will be key. Comparing 
these levels to the ones observed in case of Wnt-3a may provide more insights regarding 
the potential advantages and disadvantages of such synthetic Wnt substitutes.  
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CHAPTER 4.   DESIGNING OPTOGENETIC PROTEINS WITH 
TUNABLE CLUSTERING PROPERTIES 
4.1   Background 
Visible light is a key mediator of signal transduction pathways in some prokaryotic 
and eukaryotic cells. In recent times, it has also emerged as a versatile tool to probe and 
investigate multiple biological phenomena which are generally light-orthogonal 
(Deisseroth 2011; Fenno et al. 2012; Repina et al. 2017). The field of “Optogenetics” uses 
genetically encoded light-responsive systems to modulate a variety of processes in living 
cells, that include, but are not limited to, controlling transcription and translation, triggering 
signaling pathways, and effecting neuronal responses (Yizhar et al. 2011; Konermann et 
al. 2013; Cao et al. 2013; Tischer and Weiner 2014; Zhang and Cu 2015). Compared to 
traditional methods for probing signal transduction processes, such as gene overexpression 
strategies and using soluble ligands, light offers several key advantages. Firstly, light is 
largely orthogonal to most endogenous signaling cascades, thus significantly reducing the 
probability of off-target effects which is one of the key concerns associated with 
overexpressed proteins and ligands. Secondly, irradiating visible radiation through lasers 
enables us to obtain high degrees of spatiotemporal control over the stimulation of specific 
cells. Thirdly, the rapid ON/OFF kinetics and the ease of modulation, which are hallmarks 
of optogenetic systems, offer us unprecedented capabilities in probing hitherto “un-
probable” features of traditional signal transduction cascades (Repina et al. 2017). Keeping 
this in mind, in collaboration with Sudrik et al. (Sudrik 2014), we attempted to design novel 
optogenetic tools by engineering a previously reported optogenetic Wnt activation 
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photoswitch based on our understanding of the canonical Wnt signaling pathway. Several 
optogenetic systems have been reported in literature in the last decade (Repina et al. 2017), 
but for our purpose, we chose to focus our efforts on the A. Thaliana Cryptochrome2-based 
dimerizing and clustering photoswitches as they formed the basis of the optogenetic Wnt 
activator mentioned earlier. 
Cryptochrome2-based Dimerizers 
Wild-type Cryptochrome2 (Cry2) is a blue-light sensitive homodimer in 
Arabidopsis thaliana which remains localized in the nucleus and acts as a transcriptional 
effector. The Cry2 protein is bound to the endogenous cofactors flavin adenine dinucleotide 
(FAD) and 5,10-methanyltetrahydrofolate (MTHF) (Liu et al. 2008). These cofactors act 
as chromophores which help Cry2 absorb blue light, resulting in its conformational change. 
This conformational change enables the Cry2 protein to interact with several other 
regulatory proteins in the nucleus, one of which is the cryptochrome-interacting basic 
helix-loop-helix protein (CIB1) (Liu et al. 2008; Zuo et al. 2011). 
In 2010, Kennedy et al. identified the minimal interacting domains of Cry2 and 
CIB1 and identified a pair of truncated proteins consisting of the photolyase homology 
region (PHR) of Cry2 (Cry2PHR) and the N-terminal residues 1-170 for CIB1 (termed 
CIBN), which retained their dimerizing activity (Kennedy et al. 2010). The authors mutated 
the nuclear localization signal (NLS) residues from both proteins, resulting in robust 
cytosolic expression and activity of both Cry2PHR and CIBN. Both Cry2-CIB1 and the 
Cry2PHR-CIBN dimerizing systems have since been used in several articles for various 
cell biological applications (Hughes et al. 2012; Wang et al. 2012; Lee et al. 2014). One 
such application was the light-induced sequestration of target intracellular effectors via a  
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Figure 19 – Clustering of Cry2PHR-mCherry as reported by Bugaj et al. (A) Cry2-
mCherry fusions form clusters upon blue light exposure. (B) These clusters have an 
average characteristic dissociation time (t1/2) of ~5.4 minutes. (C) Cry2PHR-
mCherry-LRP6c fusions robustly activate Wnt signaling in presence of blue light. 
Reprinted with permission from Nature Publishing Group (Bugaj et al. 2013). 
 
multimeric protein (MP). In 2014, Lee et al. demonstrated that the fusion of a subunit of a  
multimeric protein (MP) and CIB1 formed a complex architecture with Cry2-mCherry in 
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the cytosol (Lee et al. 2014). Upon conjugating antigen-specific single-domain antibodies 
to Cry2, Lee et al. optically trapped specific proteins and disrupted their activity in the cell.  
Cryptochrome2-based Clustering Tools 
In 2013, Bugaj et al. reported that Cry2PHR is capable of clustering robustly by 
itself when exposed to blue light (Fig. 19A-B) (Bugaj et al. 2013). In the same article, they 
fused the cytosolic domain of the Wnt co-receptor LRP6 (termed LRP6c) to the C-terminus 
of Cry2PHR and showed that Wnt signaling was robustly activated when the fusion protein 
Cry2PHR-mCherry-LRP6c underwent clustering upon blue light exposure, as predicted by 
Cong et al. in 2004 (Fig. 19C) (Cong et al. 2004). They further went on to use the clustering 
properties of Cry2PHR to activate Rho-GTPases, RhoA and Rac1, thus establishing its 
utility in triggering diverse signal transduction cascades.  
In 2014, Taslimi et al. reported another optogenetic clustering tool termed Cry2olig 
containing a single E490G mutation in Cry2PHR that dramatically increased the clustering 
efficiency of the construct previously reported by Bugaj et al. (Taslimi et al. 2014). In 
contrast to Lee et al., whose method required the additional expression of a separate CIB1-
fused multimeric protein, Taslimi et al. perturbed protein activity by just fusing an effector 
protein to Cry2olig, requiring no other protein partners.  
Previously, Sudrik had reported the novel clustering tool CL6m5 which underwent 
robust clustering when exposed to blue light (Sudrik 2014). In this study, we validated his 
findings and extended the idea to develop a library of novel clustering tools (called 
CL6mN) with a range of clustering dissociation half-lives, high clustering efficiencies and 
large sizes by engineering the Cry2PHR-mCherry-LRP6c fusion protein reported by Bugaj 
et al. These clustering tools have half-lives intermediate to that reported by Bugaj et al. and 
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Taslimi et al. and can thus be used to probe protein-protein interactions at several time 
scales.  
4.2   Material and Methods 
Plasmids 
The CL6mN constructs (N=3,5) were prepared in a pmCherry-N1 vector backbone 
(Addgene#26866) expressing the Cry2(1-498)-mCherry fusion protein. The LRP6c 
fragments with the appropriate number of mutated PPPSP motifs were custom-synthesized 
from GenScript and cloned in between the Bsr GI and Xba I sites in the C-terminus of the 
pCry2PHR-mCherry insert (Addgene#26866). The Wnt-responsive 7x TFP-luciferase 
reporter plasmid was constructed as mentioned in section 3.2. 
Cell Culture and Transfections 
293T cells were cultured in a 4-chamber 35 mm glass-bottomed (1.5) dish (Cellvis) coated 
with poly-L-lysine using the conditions mentioned in previous chapters. Cells were grown 
up to ~90% confluency in each chamber (~24 hours after plating) and transfected with the 
respective CL6mN constructs using the Lipofectamine 2000 transfection reagent following 
the manufacturer’s protocol for 24-well plates.  
Confocal Microscopy 
CL6mN and Cry2PHR-mCherry transfected cells in the imaging dishes were handled 
exclusively in the dark or in the presence of a monochromatic red LED strip (Superbright 
LEDs) to avoid accidental clustering in presence of white/blue light. Cells were washed 
with imaging media consisting of 90% Fluorobrite DMEM (Thermo Fisher) supplemented 
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with 10% Fetal Bovine Serum (FBS), 1x Glutamax and 20 mM HEPES buffer. After 
washing, the cells in each chamber were incubated in 500 µL of above-mentioned imaging 
media. The imaging dish was then wrapped completely in an aluminum wrap (to prevent 
accidental clustering) before proceeding to image in the Optical Microscopy Core. The 
488-nm (GFP) laser in the Perkin Elmer Spinning Disk Microscope (located in the Optical 
Microscopy Core at EBB) was used to trigger the clustering of CL6mN and Cry2PHR cells 
at 10% and 100% intensity with a 1-second exposure per pixel. The clustering and 
declustering dynamics were observed using the 561-nm (RFP) channel. 
Quantifying Number of Clusters in Confocal Microscopy Image 
ImageJ version 1.48v was used to analyze all confocal microscopy images. Manual 
thresholding was applied individually to each image so that only the clusters were visible. 
The “Analyze Particles” feature of ImageJ was then used to count the number of clusters 
in each image. The calculated number of clusters were plotted against the respective time-
points in GraphPad Prism or MS Excel to obtain the clustering and declustering curves.  
4.3   Results  
4.3.1   Generating optogenetic clustering proteins by mutating PPPS/TP motifs in 
Cry2PHR-mCherry-LRP6c 
In their seminal paper in 2013, Bugaj et al. reported the fusion protein Cry2PHR-
mCherry-LRP6c that triggered canonical Wnt signaling in a blue-light dependent fashion 
(Bugaj et al. 2013). When we monitored the cluster formation of the above fusion protein, 
we observed significantly different ON/OFF kinetics to that of wild-type Cry2PHR-
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mCherry (data not shown). Based on this observation, we hypothesized that variants of 
Cry2PHR-mCherry-LRP6c – mutated so that the protein could no longer activate Wnt 
signaling –  would act as novel scaffolds for optogenetic proteins with vastly different and 
tunable dynamics compared to Cry2PHR-mCherry. 
 
Figure 20 – Schematic Showing Strategy to Generate CL6mN Mutants: CL6m5 
mutant is constructed by mutating five Ser/Thr residues in Cry2-mCh-LRP6c to Ala. 
CL6m3 mutant is constructed by truncating 2 PPPAP motifs from the C-terminus of 
CL6m5. 
Since the Cry2PHR-mCherry-LRP6c fusion protein activates canonical Wnt 
signaling in presence of blue light, eliminating the above signaling activity upon clustering 
represented a key first step in generating a broadly applicable and tunable optogenetic 
scaffold. Macdonald et al. in 2008 reported that five PPPS/TP motifs in the cytosolic 
domain of LRP6 play a key role in its capability to trigger Wnt signaling upon 
oligomerization (Macdonald et al. 2008). They showed that mutating these PPPS/TP motifs 
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and/or eliminating two or more such motifs completely abrogated the signaling activity of 
LRP6. Taking a page out of their book, we replaced the LRP6c in the Cry2PHR-mCherry-
LRP6c fusion protein with the mutated LRP6m5 protein, which contains five S/T®A 
mutations in the five PPPS/TP motifs (Fig. 20). Macdonald et al. also alluded to inter-motif 
interactions among the PPPSP motifs contributing to LRP6 oligomerization during Wnt 
signaling activation. We hypothesized that changing the number of “sticky” PPPAP motifs 
could result in tunable clustering/declustering dynamics in the mutated Cry2PHR-
mCherry-LRP6c proteins.  
 
Figure 21 – Luciferase Assay to Monitor Wnt Signaling Activity of CL6mN (N=3,5) 
Mutants in Light and Dark: Cry2PHR and mCherry were negative controls, 
transiently transfected instead of CL6mN on the same vector backbone. Wnt-3a + 
mCherry transfected sample was the positive control. Two-way (mixed model) 
ANOVA was performed to analyze the effect of i) light and ii) transfected constructs 
on the cells. p<0.05 for the effect of transfected constructs (H2); p>>0.05 for the effect 
of light (H1) and interaction between light and transfected constructs (H3). **p<0.05 
by performing post-hoc pairwise Tukey’s HSD test. ns = not statistically significant. 
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The resulting fusion protein library was termed CL6mN (Cry2PHR-mCherry-LRP6 with 
N mutated PPPSP motifs), where N represented the number of PPPAP motifs in the C-
terminus of the fusion protein (N=3,5). 
4.3.2   CL6mN does not trigger canonical Wnt signaling pathway 
To test whether CL6mN triggered the canonical Wnt signaling pathway, we co-
transfected 293T cells with the 7xTFP-luciferase reporter and the CL6mN constructs. Upon 
exposure to blue light, no significant increase in luciferase signal was observed for cells 
transfected with any of the CL6mN constructs (Fig. 21). In contrast, the Wnt-3a transfected 
cells showed high luciferase signals both in the presence and absence of blue light (Fig. 
21). This experiment confirmed that CL6mN constructs do not activate canonical Wnt 
signaling in the presence or absence of blue light in the cell. 
4.3.3   CL6mN exhibited robust clustering in the presence of blue light 
To analyse whether the CL6mN constructs retain their clustering activity, we 
transfected multiple wells of 293T cells with plasmids expressing CL6mN proteins. We 
subsequently imaged these samples using confocal microscopy approximately 24 hours 
after transfection. When imaged using the l=561 nm (RFP) laser, all the CL6mN constructs 
appeared homogenously distributed within the cell in the absence of blue light (l=488 nm). 
However, upon irradiation with the 488-nm laser, bright red puncta formed within the cell, 
suggesting that CL6mN proteins clustered robustly in the presence of blue light (Fig. 22). 
Combining our observations from Fig. 21 and Fig. 22, we concluded that the CL6mN 
proteins are capable of clustering in the presence of blue light while exhibiting no canonical 
Wnt signaling activity. 
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Figure 22 – Confocal Microscopy Images Showing Clustering of Cry2PHR-mCherry 
(Row 1), CL6m3 (Row 2) and CL6m5 (Row 3) at Various Time Points (T) after Blue 
Light (l=488-nm) Exposure Visualized under the RFP (l=561-nm) channel. The 
clustering is characterized by the formation of distinct puncta by the fused mCherry 




4.3.4   Differences in Cry2PHR-mCherry, CL6m3 and CL6m5 clustering (ON rate) 
dynamics are not statistically significant  
To monitor the clustering dynamics (the ON rate) of the CL6mN constructs, we 
transfected 293T cells in a 4-chambered imaging dish with respective CL6mN constructs. 
Using the 561-nm laser in the confocal microscope, we first imaged a transfected cell with 
a homogenous mCherry, and thus CL6mN, signal. We then triggered the clustering of 
CL6mN by exposing the cell to the blue (l=488 nm) laser at 100% intensity for ~1 sec and 
used the RFP channel to obtain images at a 10 second interval for 100 seconds. Next, we 
used ImageJ to analyse the number of clusters in each image to obtain the temporal 
dynamics of CL6mN clustering. When these clustering curves were compared, we 
observed that the differences in half-maximal clustering times of Cry2PHR, CL6m3 and 
CL6m5 constructs were not statistically significant (Fig. 23A-C). 
4.3.5   Preliminary evidence suggests half-lives of CL6mN clusters can be increased by 
increasing the number (N) of PPPAP motifs 
To characterize the declustering dynamics of different CL6mN constructs, we 
exposed the CL6mN expressing cells to the 488-nm laser at 10% intensity four times to 
ensure maximal clustering of CL6mN. Upon doing so, we imaged the samples every 30 
seconds using the RFP channel for a total of 20 minutes. Next, we used ImageJ to measure 
the number of clusters in each image (corresponding to a distinct time-point) to construct 




Figure 23 – Comparison of the Clustering Dynamics of (A) Cry2PHR, (B) CL6m3 
and (C) CL6m5 upon blue light exposure. Each data point represents the mean (± 1 
s.d.) of three independent experimental repeats (n=3 replicates). A variable slope Hill 
curve is fitted to the experimental observations to estimate T1/2, the time at which the 
half-maximal number of clusters are observed. 
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Figure 24 – Representative Plots Showing the Declustering Dynamics of CL6m3 and 
CL6m5 at Different Temperatures (T=25°C and T=37°C respectively). Each data 
point represents the normalized number of clusters from one experimental repeat. 
An exponential curve was used to fit the temporal dissociation dynamics of CL6m3 
and CL6m5. Final declustering half-life estimates for CL6m3 and CL6m5 were 
obtained from three independent experimental repeats, which are reported in Table 
2. 
We observed that the half-lives of the CL6mN clusters increased with the number of 
PPPAP motifs, i.e., the half-life of CL6m5 > CL6m3 > Cry2PHR with the average half-
life of CL6m5 being ~24.8 minutes (Fig. 24, Table 2) compared to ~11.55 minutes for 
CL6m3 (Fig. 24, Table 2) and ~3.85 minutes for Cry2PHR (Fig. 19B). Additionally, the 
declustering half-lives of the CL6mN mutants vary considerably with temperature, 
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decreasing to ~3.85 minutes and ~11.55 minutes at 37°C for CL6m3 and CL6m5 
respectively (Fig. 24, Table 2). From a qualitative perspective, the CL6mN constructs 
showed higher clustering efficiency and formed much more stable clusters than wild-type 
Cry2PHR, thus suggesting that CL6mN can be continuously clustered using much lower 
doses of light than is needed in case of Cry2PHR. 
Table 2 – Declustering Half-Lives of CL6mN at Different Temperatures 
Optogenetic Proteins 
Dissociation Half-Lives (in minutes) 
At 25°C (mean ± s.d.) 
n = 3 replicates 
At 37°C (mean ± s.d.) 
n = 3 replicates 
CL6m3 11.55 ± 0.0 3.85 ± 0.0 
CL6m5 24.83 ± 7.0 11.55 ± 0.0 
To summarize,  
1.   We have constructed a library of optogenetic tools which undergo robust, reversible 
and efficient clustering in presence of blue light. 
2.   The optogenetic tools do not exhibit significantly different clustering dynamics but 
they have very different declustering half-lives, thus expanding the applicability of 
these tools in investigating biological phenomena of different time scales.  
3.   The dissociation kinetics of these optogenetic photoswitches are temperature-




4.4   Discussions 
4.4.1   Potential reasons for temperature-dependence of declustering dynamics 
The exact mechanisms behind blue-light dependent cryptochrome2 (Cry2) 
clustering and declustering are not known. However, it has been hypothesized that in the 
presence of blue light, the Cry2 proteins undergo conformational changes that favour Cry2-
Cry2 interaction, resulting in the formation of visible clusters. Presumably, the absence of 
blue light results in the relaxation of the chromophores FAD and MTHF, resulting in Cry2 
reverting to its “inactive” conformation. Based on our observations, we hypothesize that 
the time scale associated with the conformational change of Cry2 stemming from the 
relaxation of its chromophores may be temperature-dependent, i.e. increased temperature 
results in a faster conformational change of the Cry2 monomer. To test this hypothesis, we 
can compare the declustering half-lives of wild-type Cry2 or Cry2PHR at different 
temperatures and monitor if the difference is significant. 
Alternatively, the temperature-dependent variation in declustering dynamics may 
be an exclusive property of the CL6mN mutants, and not of wild-type Cry2PHR. The 
interaction between the PPPAP motifs may vary with temperature, with a higher 
temperature favouring faster dissociation of these PPPAP motifs. Further studies are 
required to confirm which of the above scenarios is more realistic. 
4.4.2   Implications for PPPAP cooperativity in CL6mN 
In 2008, Macdonald et al. reported a role for cooperativity and synergy among the 
PPP(S/T)P motifs of LRP6 in activating the canonical Wnt signaling cascade. Firstly, the 
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observed difference of declustering dynamics among the Cry2PHR and CL6mN constructs 
suggests that the cooperativity and synergies among the motifs are retained even after the 
mutation of the Ser/Thr residues to Ala. Secondly, the ability of the PPPAP motifs to 
effectively increase the lifetime of these Cry2-based homo-oligomers (clusters) suggests 
that such cooperativity may in fact involve both intra- and/or inter-protein interactions. In 
the future, one can design constructs with different numbers and types of unmutated 
PPP(S/T)P motifs on the C-terminus of the Cry2-mCh-LRP6c. Monitoring the dissociation 
dynamics of the resulting proteins may give us important clues in delineating the roles of 
each distinct PPP(S/T)P motif in transducing the canonical Wnt signal via phosphorylation 
and oligomerization of LRP6. 
4.4.3   Considerations for generating stably transfected cell lines 
To further characterize and use the CL6mN constructs for other applications, one will 
presumably have to develop novel cell lines stably expressing the CL6mN constructs. We 
recommend that special attention is given to the steady-state level of the CL6mN proteins 
in such cell lines. We have observed that, at high intracellular concentrations, the CL6mN 
proteins show a tendency to cluster in the absence of blue light, as evidenced by significant 
puncta formation in the mCherry channel even in the dark. In transient transfection-based 
assays, researchers have bypassed this problem by either imaging the cells within specific 
time windows following transfection, or by treating the cells with cycloheximide to inhibit 
protein synthesis to maintain a desired intracellular protein concentration. In case of stable 
cell lines, however, controlling the genomic site of integration and the strength of the 
upstream promoter for the respective CL6mN constructs can ensure an optimal intracellular 
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concentration. The above-mentioned considerations are by no means exhaustive, but rather 
represent a “starting point” for the development of any such transgenic cell line. 
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CHAPTER 5.   DESIGNING TRANSCRIPTION ACTIVATION 
BASED REPORTERS FOR MONITORING CARDIOMYOCYTE 
DIFFERENTIATION 
5.1   Background 
Spatiotemporally controlling the self-renewal, proliferation and differentiation of 
various kinds of stem cells, e.g., embryonic stem cells, neural stem cells, mesenchymal 
stem cells, represents the central aim of regenerative medicine (Nusse 2008; Vallier et al. 
2009; Tabar and Studer 2014). Over the last 20 years, it has become evident that the above 
phenomena are intricate stepwise processes involving a defined sequence of changes in cell 
fate (Tabar and Studer 2014). Such changes are rarely accomplished by any one 
developmental signal, but rather by a combination of several signals. Moreover, in contrast 
to having a binary response to these signals, concentrations of these signaling molecules, 
finely controlled by the microenvironmental niche of the residing stem cells, have been 
shown to play a key role in moderating the lineage commitment of the stem cells (Blank et 
al. 2008). A number of pivotal signaling pathways have been identified to influence these 
processes, involving molecules belonging to the Wnt, Hedgehog, BMP, FGF families 
(Pires DaSilva and Sommer 2003; Nusse 2008).  
As is the signature of a nascent field, the role of Wnt signaling in controlling stem 
cell fate remains largely controversial (Sato et al. 2004; Reya and Clevers 2005; Davidson 
et al. 2012). In the early 2000-s, canonical Wnt signaling was largely thought to promote 
the maintenance of undifferentiated embryonic stem cells and even self-renewal in 
embryonic and neural stem cells (Sato et al. 2004; Reya and Clevers 2005). However, 
 77 
several studies in the late 2000-s and early 2010-s reported the dual nature of Wnt signaling 
by highlighting its role in promoting multi-lineage differentiation of embryonic stem cells 
(Davidson et al. 2012; Szemes et al. 2018). What is evident is that canonical Wnt signaling 
remains mired in controversy and further studies are required to satisfactorily correlate the 
role of Wnt signaling to stem cell fate in a context-dependent manner. To do so, designing 
a variety of robust reporters capable of correlating Wnt activity to various cell lineages and 
phenotypes holds great promise.  
In 2012, Lian et al. robustly generated human cardiomyocytes from human 
pluripotent stem cells by exclusively controlling canonical Wnt signaling temporally (Lian 
et al. 2012; Lian et al. 2013; Lian et al. 2015). Subsequently in 2017, Bao et al. used a 
similar strategy of temporally controlling Wnt signaling to generate long-term self-
renewing epicardial cells from human pluripotent stem cells (hPSCs) (Bao et al. 2017). The 
close alignment of these processes provides the ideal test bed for us to try and explore how 
canonical Wnt signaling influences the process of different lineages arising from similar 
initial cell populations.  
In the state-of-the-art reporters, unique biomarkers for the different intermediate 
stages of hPSC differentiation are detected usually via flow cytometry or immunoblotting 
(Lian et al. 2013; Bao et al. 2017; Schwach et al. 2017). Despite having moderate success, 
such reporters are largely low-throughput and have severe limitations under certain 
conditions. The following work is a primer describing our strategy to design 
transcriptional-activation based switches as reporters for the different intermediate stages 
of differentiation as the hPSC population commits to one fate or the other. Successfully 
deploying these reporters in stably transfected “sentinel” cells could help us satisfactorily 
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correlate canonical Wnt activity to cardiomyocyte differentiation in human pluripotent 
stem cells. 
5.2   Material and Methods 
Plasmids 
The Brachyury and Coup-TFII transcription factor sequences were inserted into the first 
cloning site (cloning site-1) of the pVitro2-MCS vector (with hygromycin resistance; 
Invivogen). A DsRed fluorescent protein sequence was inserted into the second cloning 
site as a marker for positive transfection of the plasmid. 
The 4x- and 8x-Brachyury reporters were constructed on the custom WT1-GFP plasmid 
backbone which was a gift from the Palecek lab (Bao et al. 2017). The 4x and 8x repeats 
of the consensus binding sequence of Brachyury were inserted upstream of a custom-
synthesized minimal promoter (minP) sequence which controlled the expression of a 
recombinant firefly luciferase protein downstream. The baseline expression of firefly 
luciferase acted as a marker for positive transfection of the reporter. 
The Coup-TFII reporter was constructed on a pVitro2-MCS backbone at the first cloning 
site. A custom-synthesized minimal promoter (minP) was cloned in place of the ferritin 
promoter in cloning site-1 and the CMV enhancer sequence was deleted. The minimal 
promoter sequence was preceeded by the consensus sequence of a promoter containing 
Coup-TFII binding sites. The firefly luciferase sequence was inserted downstream of the 
minimal promoter. 
All custom gene synthesis steps were performed by Gene Universal. 
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Luciferase Assay to Detect Transcription Activation 
293T cells were seeded in 96-well plates coated with poly-L-lysine at an initial density of 
60,000 cells per well and grown up to ~90% confluency in ~24 hours. Cells were co-
transfected with two separate plasmids, one encoding the transcription factor or a control 
protein, and the other encoding the reporter or an appropriate control. Transfection was 
performed by using the Lipofectamine 2000 reagent according to the manufacturer’s 
protocol. After transfection, cells were incubated for 36 hours, washed twice with DPBS 
and lysed in a passive lysis buffer (Promega). Luciferase Assay Substrate (Promega) was 
subsequently added to the lysate upon transferring to a white-walled opaque 96-well plate 
(Corning) and the luminescence read in the BioTek Synergy plate reader in the EBB 
Biopolymer Characterization Core. 
5.3   Results and Discussion 
5.3.1   Brachyury and Coup-TFII as biomarkers for mesodermal precursor cells and 
cardiomyocytes 
In 2012, Lian et al. first reported obtaining functional (beating) cardiomyocytes 
from human pluripotent stem cells (hPSCs) by modulating the canonical Wnt signal only 
over time (Lian et al. 2012). The seminal study was followed by multiple reports between 
2014 – 2017 by Lian et al. and Bao et al. that described the generation of endothelial cell 
and long-term self-renewing epicardial cell populations respectively by hPSC 
differentiation (Fig. 25). 
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Figure 25 – Flow Chart showing the Intermediate Cell Types in the Differentiation of 
human Pluripotent Stem Cells (hPSCs) to form Epicardial cells, Endothelial cells and 
Cardiomyocytes. Reprinted with permission from Nature Publishing Group (Bao et 
al. 2017). 
 The process through which hPSCs differentiate to form three distinct cell 
populations is largely thought to follow the sequence described in Fig. 25. Upon Wnt 
activation, hPSCs differentiate to form mesodermal precursor cell populations which can, 
in turn, form endothelial cell layers if Wnt remains turned on. Subsequently, when Wnt is 
downregulated, mesodermal precursors differentiate to form cardiac progenitor cells which 
can give rise to multiple different types of cardiac cells, depending on the temporal 
variation of Wnt signaling. If canonical Wnt signaling remains downregulated, cardiac 
progenitors are thought to predominantly give rise to atrial and ventricular cardiomyocytes, 
whereas a second Wnt upregulation step leads to the formation of epicardial cells. 
 To leverage the above process for robust and scalable synthesis of cardiomyocytes, 




case, biological reporters that are specific to the signature biomarkers of these intermediate 
cell specifications, i.e. mesodermal precursors, cardiac progenitor cells, atrial and 
ventricular cardiomyocytes, can serve as these necessary quality indicators. 
 Based on a vast literature review, we found that  
a.   The T-box transcription factor Brachyury is a specific marker for mesodermal 
precursor cells (Wilson et al. 1995; Kubo et al. 2004; Tada et al. 2005; Bao et al. 2017).  
b.   The transcription factors Isl1 and Nkx2.5 can serve as biomarkers for the cardiac 
progenitor cell population (Cai et al. 2003; Elliott et al. 2011) 
c.   The transcription factors Coup-TFII and GATA4 are specifically expressed in the atrial 
and ventricular cardiomyocyte cell populations respectively (Holtzinger et al. 2010; 
Wu et al. 2013).  
In this chapter, we analyzed the sequences and structures of the transcription factors 
Brachyury and Coup-TFII. Based on our findings, we designed and tested reporters that 
upregulated the expression of luciferase upon the expression of the above-mentioned 
transcription factors. 
5.3.2   Biophysics of Brachyury and Coup-TFII Transcription Factors 
Brachyury belongs to the family of T-box transcription factors and is capable of 
binding to the specific T-box consensus DNA sequence 5’-TCACACCT-3’ (Kusch et al. 
2002; Lolas et al. 2014). Brachyury has a relatively large DNA binding domain that spans 
amino acid residues 51-219, which is roughly 1/3rd the length of the entire 436 amino acid-
long protein. Brachyury functions as a dimer in vivo and each subunit of the Brachyury 
dimer binds to the consensus T-box sequence (Fig. 26A) (Muller and Herrmann 1997). 
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Figure 26 – Activation of Transcription by Brachyury: (A) Crystal structure showing 
that Brachyury is capable of binding to the consensus T-box DNA sequence (Uniprot# 
6F58). (B) Schematic showing the strategy to design transcription-activation based 
reporters of Brachyury activity. 
Once bound to the consensus sequence in the enhancer regions, the Brachyury dimer is 
capable of recruiting RNA Polymerase II and upregulating the transcription of downstream 
genes (Fig. 26B). 
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Figure 27 – Schematic Showing Proposed Strategy to Design Coup-TFII-responsive 
Transcription-Activation Based Reporter. 
The chicken ovalbumin upstream promoter-transcription factor II (Coup-TFII) is 
an orphan nuclear receptor which is hypothesized to be a ligand-activated transcription 
factor, but the activating ligands have not been identified conclusively in vivo (Kruse et al. 
2008). Like Brachyury, it contains a DNA binding domain that spans amino acids 76-151. 
However, unlike Brachyury, Coup-TFII contains two zinc finger domains which are 
thought to enable its interactions with other protein partners in the nucleus to upregulate 
transcription. Coup-TFII has been reported to bind to imperfect direct repeats of the DNA 
hexamer 5’-AGGTCA-3’ in the promoter regions of downstream genes to upregulate 
transcription in a promoter-dependent fashion (Fig. 27) (Lee et al. 2012). Unlike 
Brachyury, no direct evidence has been reported to date as to whether binding to the 
consensus DNA hexamer is sufficient for Coup-TFII to recruit RNA Polymerase II and 




Figure 28 – Preliminary Evidence of Transcription-Activation Based Reporters (4x 
and 8x) Showing Significant Fold Increase in Luminescence in presence of Brachyury. 
The fold change increases with increase in Brachyury-to-reporter ratio for both 4x 
and 8x reporters. Each bar represents the mean (± 1 s.d.) of 3 replicates (n=3). 
5.3.3   Transcription Activation-based Reporters for Brachyury and Coup-TFII 
The Brachyury and Coup-TFII transcription activation-based reporters were 
constructed on custom plasmids containing the homology-directed repair (HDR) arms for 
editing the locus expressing the WT1 gene in the human genome. We designed two distinct 
Brachyury-responsive reporters, one with 4 repeats and the other with 8 repeats of the 
consensus T-box DNA octamer sequence 5’- TCACACCT-3’ in the enhancer region (Lolas 
et al. 2014). The octamer sequences were upstream of a minimal promoter which controlled 
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the expression of a downstream luciferase gene. The spacing between successive repeats 
alternated between 5 bp and 22 bp to account for the in vivo dimerized form of active 
Brachyury. Upon transient transfection of the reporters along with a plasmid expressing 
recombinant human Brachyury or an orthogonal vector control plasmid, both 4x- and 8x-
CBS (consensus binding site) reporters showed robust increase in luciferase expression in 
presence of Brachyury compared to the orthogonal control (Fig. 28). Predictably, the fold 
activation was higher in case of the reporter containing 8 CBS repeats (~5 folds compared 
to ~4 folds). Interestingly, the magnitude of the luminescence signals was lower in case of 
the 8x-reporter (data not shown), thus posing a potential signal-to-noise optimization 
problem for the future. 
For Coup-TFII, we used the same vector backbone, but in this case, we inserted a 
truncated, functional region of the Coup-responsive enhancer upstream of the minimal 
promoter and luciferase gene (Kruse et al. 2008). Following a similar transient transfection 
strategy described above, we confirmed that the Coup-TFII reporter showed a ~3-fold 
increase in downstream luciferase expression in presence of the Coup-TFII transcription 
factor expressing plasmid compared to an orthogonal control (Fig. 29). 
To conclude, 
1.   We conceptualized a transcription-activation based strategy to distinguish specific 
cell populations in the cardiomyocyte differentiation process. 
2.   As a proof-of-concept, we designed robust transcriptional-activation based 




Figure 29 – Preliminary Evidence of Coup-TFII Transcription-Activation Based 
Reporter Showing Fold Increase in Luminescence in Presence of Coup-TFII at 
Various Levels of Transfected Reporter and Transcription Factor. Each bar 
represents the mean (± 1 s.d.) of 3 replicates (n=3). 
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CHAPTER 6.   POTENTIAL FUTURE WORK 
In this thesis, we established a model elucidating the fundamental mechanism of 
canonical Wnt signal transduction through the cytosol. The model can serve as a reliable 
framework to evaluate the nuances of canonical Wnt signaling across different cell types 
and culture conditions. Next, we proceeded to leverage our understanding of Wnt signaling 
to design synthetic agonists capable of robustly triggering the canonical Wnt pathway. Our 
approach is highly synergistic with bioprocesses that are well-established in the industry 
and can thus serve as a platform to synthesize alternatives to the canonical Wnt ligand(s). 
We further applied our understanding of the structure of LRP6, a membrane-bound 
receptor pivotal in Wnt signal transduction, to design a library of optogenetic 
photoswitches possessing tunable declustering dynamics. The above optogenetic proteins, 
termed CL6mN, can be deployed to significantly reduce cytotoxicity and to probe cellular 
phenomena of wide-ranging time scales. In this chapter, we discuss some potentially 
promising applications of these tools for the future. 
6.1   Correlating Destruction Complex Localization to Cell Fate 
We established in Chapter 5 that the role of the canonical Wnt signal in stem cell fate 
determination is highly context-dependent. In 2013, Habib et al. wanted to probe the 
consequences of local Wnt signals on cultured embryonic stem cells (ESCs) and found that 
during cell division, the Wnt-proximal daughter cells inherited high levels of nuclear b-
catenin and pluripotency genes whereas Wnt-distal daughter cells showed signs of 
differentiation (Habib et al. 2013). In vivo, this result magnifies the significance of the 
spatial distribution and the gradient of Wnt molecules in the microenvironment of stem 
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cells. A binary model of Wnt signaling (where signaling is either ON or OFF) does not 
satisfactorily explain the nuances involved in this process of cell fate determination. In our 
model, we find that a certain fraction (56%) of the destruction complexes relocates to the 
membrane and this fraction is key in determining the fold increase in cytosolic b-catenin, 
and thus the extent of downstream signaling. Since this relocation is primarily thought to 
be driven by the interaction of Axin1 and Wnt-activated LRP6, we can speculate that the 
percentage of destruction complex relocating is a function of the concentration and 
affinity/avidity of heterodimeric Fzd-LRP6 complexes formed upon Wnt-3a stimulation 
towards the intracellular destruction complexes. Our model thus provides a fundamental 
basis for correlating destruction complex localization to the extent of Wnt-downstream 
gene activation. In the future, an extensive model-driven study may be warranted to 
investigate whether certain regimes of Wnt signaling correlate to specific cell fates. The 
questions to ask will be: 
1.   Is the percentage of destruction complex relocating to the membrane tunable? If so, 
what are the contributing factors? 
2.   Do we observe any experimental limits (both higher and lower) of destruction 
complex localization in the presence of Wnt-3a? 
3.   Do these limits correspond to certain cell fates in human pluripotent stem cells? 




6.2   Potent Multivalent Wnt Agonists for Unexplored Regimes of Wnt Signaling 
In Chapter 3, we provided a proof-of-concept that synthetic heterodimers can 
successfully activate canonical Wnt signaling. To further enhance the potency of the 
agonists, we propose designing variants with higher valencies of the receptor-binding 
ligands. We propose three distinct strategies to do so. 
1.   Using SpyTag-SpyCatcher chemistry, we intend to conjugate an anti-Fzd monoclonal 
antibody (mAb) to two LRP6 Fabs to obtain a “dimer of dimers” capable of triggering 
canonical Wnt signaling. 
2.   In the second approach, we propose to tether multiple copies of the synthetic 
heterodimer onto the surfaces of bacteriophage MS2 virus-like particles (VLPs) and 
investigate their potency in triggering canonical Wnt signaling. Introducing an AviTag 
into the sequence of a Fab heavy chain will allow us to conjugate a biotin to the Wnt 
heterodimer. Coating the VLP surface with streptavidin will allow us to robustly 
generate multivalent Wnt agonists of tunable potency.  
3.   Finally, we can use flexible scaffolds in place of the MS2 VLPs to generate another 
class of multivalent Wnt agonists. 
On a different note, we can extend this strategy of coupling specific antibodies or single 
chain/multi-unit antibody fragments to target other aspects of the canonical, and even non-
canonical, Wnt pathways. Recently, Luca et al. reported surrogate R-Spondin agonists 
which further amplify the effect of canonical Wnt ligands, a pathway that can also be 
successfully targeted using our strategy (Luca et al. 2019). Further, multiple noncanonical 
Wnt pathways mediated by Wnt-5a are hypothesized to propagate through the assembly of 
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co-receptors Frizzled and ROR2 or RYK proteins, which are tyrosine-kinase like receptors 
in the plasma membrane (Ho et al. 2012; Green et al. 2014). One key reason why these 
pathways have remained unexplored is the significant lack of natural ligands that 
specifically target ROR2 and RYK, so much so that these receptors were thought to be 
“orphan receptors” until very recently. However, antibody and/or antibody fragments 
specific to these proteins are abundant, which gives our strategy a unique advantage in 
generating synthetic noncanonical Wnt agonists. 
6.3   Potent Optogenetic Activators of Rho GTPases 
Optogenetic signaling activators hold immense promise in providing several novel 
insights into a variety of cellular phenomena. Along the way, blue-light mediated 
cytotoxicity may become a roadblock. Using the CL6mN photoswitches instead of the 
wild-type Cry2 or Cry2PHR may ameliorate this problem to a certain extent. In their 
seminal 2013 article, Bugaj et al. reported the activation of the Rho GTPase-s Rac1 and 
RhoA upon blue-light mediated oligomerization of the fusion proteins Cry2-Rac1 and 
Cry2-RhoA respectively. One can fuse the Rac1 and RhoA constructs to the C-terminus of 
CL6mN constructs and characterize their level of activation upon blue-light exposure, in a 
very similar vein to that of Bugaj et al. Upon doing so, one can compare the levels of 
activated Rho GTPases in the Cry2-Rho GTPase fusion and the CL6mN-Rho GTPase 
fusion respectively. We hypothesize that for similar levels of Rho GTPase activation, 
significantly less blue-light exposure will be required, thus supporting CL6mN-s’ ability 
to reduce blue-light mediated cytotoxicity in cell biological applications. 
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6.4   Optogenetic Inhibitors of Nuclear Translocation of b-catenin 
The effects of introducing developmental signals on several key cellular phenomena 
have been well-characterized in the past several decades. How the cell responds to the 
withdrawal of such signals, however, remains largely unexplored. The optogenetic tools 
developed in this thesis can offer us an avenue to investigate aspects of such signal 
withdrawal in a variety of developmental pathways. As a proof-of-concept, we may 
proceed by generating a blue-light dependent Wnt OFF switch. To do so, we can use fusion 
proteins consisting of the CL6mN proteins on the N-terminus and a single-chain b-catenin 
binding protein on the C-terminus. Such a fusion protein may be able to recruit b-catenin 
in a CL6mN cluster in a blue-light dependent fashion. The large size of these clusters may 
subsequently render the recruited b-catenin incapable of translocating to the nucleus.  
In theory, such an OFF switch can be generated for several such developmental 
pathways, e.g. the TGF-b pathways, which involve the translocation of transcriptional co-
activator SMAD proteins to the nucleus, and the Hippo signaling pathway, which involves 
the YAP/TAZ proteins migrating to the nucleus from the cytosol. If successfully 
implemented, such switches can provide fundamental insights into a hitherto unexplored 
regime of developmental signaling pathways. 
6.5   Stably-transfected “Sentinel Cells” to Correlate Wnt Signaling with Stem Cell 
Fate and Monitor Therapeutic Cell Quality 
We intend to strategically deploy the transcription-activation based reporters we 
designed in Chapter 5 to monitor the quality of cardiomyocytes produced from human 
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induced pluripotent stem cells (iPSCs). To do so, we first need to design robust reporters 
for cardiac progenitor cells as well as for ventricular cardiomyocytes. Transcription factors 
such as Isl-1 or Nkx2.5 may form the basis of such reporters in cardiac progenitor cells 
while GATA4 may be used to detect ventricular cardiomyocytes. Upon establishing the 
library of reporters, we intend to use Cas9-mediated genome editing to stably integrate 
these reporters into induced pluripotent stem cells (iPSCs). Putting multiple types of 
luciferase or fluorescent indicators downstream of these reporters will enable us to 
accurately report the cell specifications in the cardiomyocyte differentiation process. The 
successful deployment of these reporters will not only make it possible to generate high 
quality cardiomyocytes from human pluripotent stem cells, but will also provide us insights 
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